CINXE.COM

Cell and gene therapy clinical development | ICON plc

<!DOCTYPE html> <html lang="en" dir="ltr"> <head> <meta charset="utf-8" /> <noscript><style>form.antibot * :not(.antibot-message) { display: none !important; }</style> </noscript><script type="text/javascript">piAId = '37932';piCId = '1732'; (function() { function async_load(){ var s = document.createElement('script'); s.type = 'text/javascript'; s.src = ('https:' == document.location.protocol ? 'https://pi' : 'http://cdn') + '.pardot.com/pd.js'; var c = document.getElementsByTagName('script')[0]; c.parentNode.insertBefore(s, c); } if(window.attachEvent) { window.attachEvent('onload', async_load); } else { window.addEventListener('load', async_load, false); } })();</script> <meta name="description" content="Clinical development of cell and gene therapies requires new workflows, processes and tools." /> <meta name="keywords" content="cgt, cell and gene therapies, cgt clinical trials" /> <link rel="canonical" href="https://www.iconplc.com/insights/therapeutics/cell-and-gene-therapies" /> <meta name="Generator" content="Drupal 10 (https://www.drupal.org)" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="icon" href="/themes/custom/iconplc/favicon.ico" type="image/vnd.microsoft.icon" /> <script src="/sites/default/files/google_tag/gtm_container_corp/google_tag.script.js?snez2n" defer></script> <script>window.a2a_config=window.a2a_config||{};a2a_config.callbacks=[];a2a_config.overlays=[];a2a_config.templates={};</script> <title>Cell and gene therapy clinical development | ICON plc</title> <link rel="stylesheet" media="all" href="/modules/contrib/ajax_loader/css/throbber-general.css?snez2n" /> <link rel="stylesheet" media="all" href="https://players.brightcove.net/videojs-bc-playlist-ui/3/videojs-bc-playlist-ui.css" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/ajax-progress.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/align.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/autocomplete-loading.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/fieldgroup.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/container-inline.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/clearfix.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/details.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/hidden.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/item-list.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/js.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/nowrap.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/position-container.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/progress.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/reset-appearance.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/resize.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/sticky-header.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/system-status-counter.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/system-status-report-counters.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/system-status-report-general-info.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/tabledrag.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/tablesort.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/system/components/tree-child.module.css?snez2n" /> <link rel="stylesheet" media="all" href="/modules/contrib/addtoany/css/addtoany.css?snez2n" /> <link rel="stylesheet" media="all" href="/modules/contrib/ajax_loader/css/fading-circle.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/layouts/layout_discovery/onecol/onecol.css?snez2n" /> <link rel="stylesheet" media="all" href="/modules/contrib/paragraphs/css/paragraphs.unpublished.css?snez2n" /> <link rel="stylesheet" media="all" href="/core/themes/stable9/css/core/assets/vendor/normalize-css/normalize.css?snez2n" /> <link rel="stylesheet" media="all" href="/themes/custom/iconplc/css/main.css?snez2n" /> <link rel="stylesheet" media="all" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" /> <link rel="stylesheet" media="all" href="/themes/custom/iconplc/css/theme/footer.css?snez2n" /> <link rel="stylesheet" media="all" href="/themes/custom/iconplc/css/theme/header.css?snez2n" /> <link rel="stylesheet" media="all" href="/libraries/slick-carousel/slick/slick.css?snez2n" /> <script>!function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="6Y2MS-QG49D-DNYL6-USZAZ-APV4F",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onload=e&&e.timeStamp||(new Date).getTime()}if(!window.BOOMR||!window.BOOMR.version&&!window.BOOMR.snippetExecuted){window.BOOMR=window.BOOMR||{},window.BOOMR.snippetStart=(new Date).getTime(),window.BOOMR.snippetExecuted=!0,window.BOOMR.snippetVersion=12,window.BOOMR.url=n+"6Y2MS-QG49D-DNYL6-USZAZ-APV4F";var i=document.currentScript||document.getElementsByTagName("script")[0],o=!1,r=document.createElement("link");if(r.relList&&"function"==typeof r.relList.supports&&r.relList.supports("preload")&&"as"in r)window.BOOMR.snippetMethod="p",r.href=window.BOOMR.url,r.rel="preload",r.as="script",r.addEventListener("load",e),r.addEventListener("error",function(){t(!0)}),setTimeout(function(){if(!o)t(!0)},3e3),BOOMR_lstart=(new Date).getTime(),i.parentNode.appendChild(r);else t(!1);if(window.addEventListener)window.addEventListener("load",a,!1);else if(window.attachEvent)window.attachEvent("onload",a)}}(),"".length>0)if(e&&"performance"in e&&e.performance&&"function"==typeof e.performance.setResourceTimingBufferSize)e.performance.setResourceTimingBufferSize();!function(){if(BOOMR=e.BOOMR||{},BOOMR.plugins=BOOMR.plugins||{},!BOOMR.plugins.AK){var n=""=="true"?1:0,t="",a="bdpnbevydn5scz2cvk5q-f-fbd6ef46f-clientnsv4-s.akamaihd.net",i="false"=="true"?2:1,o={"ak.v":"39","ak.cp":"1488202","ak.ai":parseInt("949150",10),"ak.ol":"0","ak.cr":0,"ak.ipv":4,"ak.proto":"http/1.1","ak.rid":"86ef422","ak.r":41571,"ak.a2":n,"ak.m":"b","ak.n":"ff","ak.bpcip":"8.222.208.0","ak.cport":42390,"ak.gh":"184.27.123.29","ak.quicv":"","ak.tlsv":"tls1.2","ak.0rtt":"","ak.0rtt.ed":"","ak.csrc":"-","ak.acc":"reno","ak.t":"1732422331","ak.ak":"hOBiQwZUYzCg5VSAfCLimQ==v6VYY5iflu3IsqTlMRaiGnbM3WQ03i8WyBIsghX0Q0LiTx0uZCszCVJ3jsN8UeEBKnE+3JYzZK4DJ2U6pIT5ZpMN93MBrSp13s/w1Gvxs/HegHhzJtqRFXnMutEM8yUStYdcJWtEoWMFcF8TgWUEaWUJ+A9erVI6Vz1xOxNzo8PxvH2U+wADd/DUbQhFG1gW+jamJaetHgW/QP8tGyjifoCpleYwEzthbMsKeVWNtkXiN9jJdx9laEVnn+xKhxKLqpnU5HHCQd5KU0ftpKC86olGznavfE29BYwLTAEQg2ZyxiENvZS1VI0rTvA9Hr/X8HSonVTpSaZ/af4YRWMCdh5b956retABEZk2DYIEkjBeTiLqX4Gb8YRruzAwQ/6VC87cmQq1nZ2WQ2jfaWRISODpqW8P557XnYRg1DIK4lk=","ak.pv":"16","ak.dpoabenc":"","ak.tf":i};if(""!==t)o["ak.ruds"]=t;var r={i:!1,av:function(n){var t="http.initiator";if(n&&(!n[t]||"spa_hard"===n[t]))o["ak.feo"]=void 0!==e.aFeoApplied?1:0,BOOMR.addVar(o)},rv:function(){var e=["ak.bpcip","ak.cport","ak.cr","ak.csrc","ak.gh","ak.ipv","ak.m","ak.n","ak.ol","ak.proto","ak.quicv","ak.tlsv","ak.0rtt","ak.0rtt.ed","ak.r","ak.acc","ak.t","ak.tf"];BOOMR.removeVar(e)}};BOOMR.plugins.AK={akVars:o,akDNSPreFetchDomain:a,init:function(){if(!r.i){var e=BOOMR.subscribe;e("before_beacon",r.av,null,null),e("onbeacon",r.rv,null,null),r.i=!0}return this},is_complete:function(){return!0}}}}()}(window);</script></head> <body class="path-node page-node-type-standard-page"> <a href="#main-content" class="focusable skip-link"> Skip to main content </a> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K6FFJM" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <div class="share-buttons share-buttons--right d-none d-md-block"> <div class="region region-social-media-share"> <div id="block-addtoanysharebuttons"> <span class="a2a_kit a2a_kit_size_19 addtoany_list" data-a2a-url="https://www.iconplc.com/insights/therapeutics/cell-and-gene-therapies" data-a2a-title="Cell and Gene Therapies"><a class="a2a_button_facebook facebook"><img src="/themes/custom/iconplc/src/assets/images/social-icons/facebook-f.svg" border="0" alt="Facebook" width="19" height="19"></a><a class="a2a_button_x twitter-x"><img src="/themes/custom/iconplc/src/assets/images/social-icons/x-twitter.svg" border="0" alt="Facebook" width="19" height="19"></a><a class="a2a_button_linkedin linkedin"><img src="/themes/custom/iconplc/src/assets/images/social-icons/linkedin-in.svg" border="0" alt="Facebook" width="19" height="19"></a></span> </div> </div> </div> <div class="layout-container"> <header role="banner"> <nav class="navbar bg-white fixed-top navbar-expand-xl" role="navigation"> <div id="block-sitebranding"> <a href="/" rel="home" class="navbar-brand"> <img src="/themes/custom/iconplc/logo.svg" alt="Home" title="Home" /> </a> </div> <button type="button" class="navbar-btn navbar-btn--search" data-toggle="modal" data-target="#search-modal"> <i class="icon-ui-search-loupe" aria-hidden="true"></i> </button> <button class="navbar-btn navbar-btn--open" type="button" data-toggle="collapse" aria-controls="site-navigation" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="navbar-btn__icon"></span> </button> <div class="collapse navbar-collapse" id="site-navigation"> <div class="navbar-navs"> <button class="navbar-btn navbar-btn--close" type="button" aria-controls="site-navigation" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-btn__icon"></span> </button> <ul data-region="primary_menu" region="primary_menu" class="navbar-nav navbar-nav-primary mr-auto"> <li class="nav-item dropdown"> <a href="/solutions" aria-expanded="false" class="nav-link dropdown-toggle" data-toggle="dropdown" role="button"> Solutions <span></span> </a> <div class="menu_link_content menu-link-contentmain view-mode-main-navigation dropdown-menu"> <button class="navbar-btn navbar-btn--back" type="button"> <span class="navbar-btn__icon"></span> </button> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-xl-3"> <div class="paragraph paragraph--type--mega-menu-text paragraph--view-mode--default"> <div class="mega-menu-title"><span class="h4">Clinical solutions</span></div> </div> <a class="dropdown-item" href="/solutions/blended-solutions">Blended Solutions</a> <a class="dropdown-item" href="/solutions/cardiac-safety-solutions">Cardiac Safety Solutions</a> <a class="dropdown-item" href="/solutions/clinical-scientific-operations">Clinical &amp; Scientific Operations</a> <a class="dropdown-item" href="/solutions/decentralised-clinical-trials">Decentralised Clinical Trials</a> <a class="dropdown-item" href="/solutions/early-clinical">Early Clinical</a> <a class="dropdown-item" href="/solutions/laboratories">Laboratories</a> <a class="dropdown-item" href="/solutions/medical-imaging">Medical Imaging</a> <a class="dropdown-item" href="/solutions/site-and-patient-solutions">Site &amp; Patient Solutions</a> <a class="dropdown-item" href="/solutions/strategic-solutions">Strategic Solutions</a> </div> <div class="col-xl-3"> <div class="mega-menu-title"> <div><span>Consulting &amp; Commercial</span></div> </div> <a href="/solutions/consulting/asset-development" class="dropdown-item" data-drupal-link-system-path="node/33869">Asset Development Consulting</a> <a href="/solutions/consulting/commercial-positioning-consulting" class="dropdown-item" data-drupal-link-system-path="node/33875">Commercial Positioning</a> <a href="/solutions/language-services" class="dropdown-item" data-drupal-link-system-path="node/33968">Language Services</a> <a href="/solutions/real-world-intelligence" class="dropdown-item" data-drupal-link-system-path="node/33972">Real World Intelligence</a> <a href="/solutions/consulting/regulatory-affairs" class="dropdown-item" data-drupal-link-system-path="node/33892">Regulatory Affairs</a> <a href="/solutions/real-world-intelligence/symphony-health" class="dropdown-item" data-drupal-link-system-path="node/34056">Symphony Health data</a> </div> <div class="col-xl-3"> <a href="/solutions/outcome-measures" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/9899e456-4ca8-42f9-bc3e-09c8de4f19f8/web/Outcome_measures_MDD.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=_baP6hiH" width="260" height="136" alt="Mega navigation image for ICON website MDD" loading="eager" title="Mega navigation image for ICON website MDD" /> </div> </div> </div> <span class="h4">Outcome Measures</span> <p class="section-overview--desktop">COAs and DHTs – measure what matters</p> </a> </div> <div class="col-xl-3"> <a href="/solutions/technologies" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/86d7484b-45a2-4ec0-8b3e-35e744ac1acf/web/Technologies-homepage%20banner.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=kSzFMCbw" width="260" height="136" alt="Technologies-homepage banner.jpg" loading="eager" title="Technologies-homepage banner.jpg" /> </div> </div> </div> <span class="h4">Technologies</span> <p class="section-overview--desktop">Technology solutions from early phase through to post-marketing.</p> </a> </div> </div> </div> </div> </li> <li class="nav-item dropdown"> <a href="/sectors" aria-expanded="false" class="nav-link dropdown-toggle" data-toggle="dropdown" role="button"> Sectors <span></span> </a> <div class="menu_link_content menu-link-contentmain view-mode-main-navigation dropdown-menu"> <button class="navbar-btn navbar-btn--back" type="button"> <span class="navbar-btn__icon"></span> </button> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-xl-3"> <div class="paragraph paragraph--type--mega-menu-text paragraph--view-mode--default"> <div class="mega-menu-title"><span class="h4">Sectors</span></div> <div class="section-overview--desktop"> <p>ICON provides its full range of clinical, consulting and commercial services across several industry sectors.</p> </div> <a class="dropdown-item section-overview--desktop" href="/sectors">Read more</a> </div> </div> <div class="col-xl-3"> <div class="mega-menu-title"> </div> <a href="/sectors/biotech" class="dropdown-item" data-drupal-link-system-path="node/33810">Biotech</a> <a href="/sectors/government-and-public-health" class="dropdown-item" data-drupal-link-system-path="node/33814">Government and Public Health</a> <a href="/sectors/medical-device" class="dropdown-item" data-drupal-link-system-path="node/33821">Medical Device</a> <a href="/sectors/pharma" class="dropdown-item" data-drupal-link-system-path="node/33827">Pharmaceuticals</a> </div> <div class="col-xl-3"> <a href="/sectors/biotech" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/9a875746-3c1e-42ad-bf90-bf10c0eb31ec/web/ICON%20Biotech%20website%20mega%20nav.png?crop=yes&amp;w=260&amp;h=136&amp;itok=p81asfWQ" width="260" height="136" alt="ICON Biotech website mega nav.png" loading="eager" title="ICON Biotech website mega nav.png" /> </div> </div> </div> <span class="h4">Biotech</span> <p class="section-overview--desktop">Developing transformative therapies requires a flexible approach.</p> </a> </div> <div class="col-xl-3"> <a href="/sectors/pharmaceuticals/partnerships" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/2e13edb4-013d-4553-aaa0-3704fe8e7939/web/icon-and-you-mdd.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=GmvVWBwu" width="260" height="136" alt="icon-and-you-mdd.jpg" loading="eager" title="icon-and-you-mdd.jpg" /> </div> </div> </div> <span class="h4">ICON and You</span> <p class="section-overview--desktop">Partners making a difference.</p> </a> </div> </div> </div> </div> </li> <li class="nav-item dropdown"> <a href="/therapeutics" aria-expanded="false" class="nav-link dropdown-toggle" data-toggle="dropdown" role="button"> Therapeutics <span></span> </a> <div class="menu_link_content menu-link-contentmain view-mode-main-navigation dropdown-menu"> <button class="navbar-btn navbar-btn--back" type="button"> <span class="navbar-btn__icon"></span> </button> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-xl-3"> <div class="paragraph paragraph--type--mega-menu-text paragraph--view-mode--default"> <div class="mega-menu-title"><a href="/therapeutics" target="_self">Therapeutics</a></div> </div> <a class="dropdown-item" href="/therapeutics/cardiovascular">Cardiovascular</a> <a class="dropdown-item" href="/therapeutics/central-nervous-system">Central Nervous System</a> <a class="dropdown-item" href="/therapeutics/endocrine-metabolic-disorders">Endocrine &amp; Metabolic Disorders</a> <a class="dropdown-item" href="/therapeutics/infectious-diseases">Infectious Diseases</a> <a class="dropdown-item" href="/therapeutics/internal-medicine-immunology">Internal Medicine &amp; Immunology</a> <a class="dropdown-item" href="/therapeutics/oncology">Oncology</a> </div> <div class="col-xl-3"> <div class="mega-menu-title"> <div><span>Cross-therapeutics</span></div> </div> <a href="/therapeutics/biosimilars" class="dropdown-item" data-drupal-link-system-path="node/33807">Biosimilars</a> <a href="/therapeutics/cell-and-gene-therapies" class="dropdown-item" data-drupal-link-system-path="node/34067">Cell and Gene Therapies</a> <a href="/therapeutics/medical-device" class="dropdown-item" data-drupal-link-system-path="node/34085">Medical Device</a> <a href="/therapeutics/pediatrics" class="dropdown-item" data-drupal-link-system-path="node/34089">Pediatrics</a> <a href="/therapeutics/rare-orphan-diseases" class="dropdown-item" data-drupal-link-system-path="node/34090">Rare &amp; Orphan Diseases</a> <a href="/therapeutics/vaccines" class="dropdown-item" data-drupal-link-system-path="node/34092">Vaccines</a> <a href="/therapeutics/womens-health" class="dropdown-item" data-drupal-link-system-path="node/34094">Women&#039;s Health</a> </div> <div class="col-xl-3"> <a href="/therapeutics/endocrine-metabolic-disorders/obesity" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/9ddd8e65-786a-4ddd-a3f8-56a75fba4ab3/web/Obesity_MDD.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=3FHb2-iA" width="260" height="136" alt="Obesity_MDD.jpg" loading="eager" title="Obesity_MDD.jpg" /> </div> </div> </div> <span class="h4">Obesity</span> <p class="section-overview--desktop">A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.</p> </a> </div> <div class="col-xl-3"> <a href="/insights/therapeutics" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/78559377-8cc3-4bc6-b6f2-cc20a04e1504/web/cells-menu-hero.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=0ESOS9pw" width="260" height="136" alt="cells-menu-hero.jpg" loading="eager" title="cells-menu-hero.jpg" /> </div> </div> </div> <span class="h4">Therapeutics insights</span> <p class="section-overview--desktop">ICON&#039;s therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more. </p> </a> </div> </div> </div> </div> </li> <li class="nav-item dropdown"> <a href="/insights" aria-expanded="false" class="nav-link dropdown-toggle" data-toggle="dropdown" role="button"> Insights <span></span> </a> <div class="menu_link_content menu-link-contentmain view-mode-main-navigation dropdown-menu"> <button class="navbar-btn navbar-btn--back" type="button"> <span class="navbar-btn__icon"></span> </button> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-xl-3"> <div class="paragraph paragraph--type--mega-menu-text paragraph--view-mode--default"> <div class="mega-menu-title"><a href="/insights" target="_self">Insights</a></div> </div> <a class="dropdown-item" href="/insights/digital-disruption">Digital Disruption</a> <a class="dropdown-item" href="/insights/patient-centricity">Patient Centricity</a> <a class="dropdown-item" href="/insights/regulatory-intelligence">Regulatory Intelligence</a> <a class="dropdown-item" href="/insights/therapeutics">Therapeutics insights</a> <a class="dropdown-item" href="/insights/transforming-trials">Transforming Trials</a> <a class="dropdown-item" href="/insights/value-based-healthcare">Value Based Healthcare</a> <a class="dropdown-item" href="/insights/blog">Blog</a> <a class="dropdown-item" href="/insights/videos">Videos</a> <a class="dropdown-item" href="https://webinars.iconplc.com">Webinar Channel</a> </div> <div class="col-xl-3"> <a href="/insights/transforming-trials/blended-solutions-insights/embracing-blended-operating-model" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/f7dc31ec-43dc-49b9-aa7b-939e5572e257/web/Blended%20solutions_MDD.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=yv16XaJb" width="260" height="136" alt="blended solutions" loading="eager" title="blended solutions" /> </div> </div> </div> <span class="h4">Embracing a blended operating model</span> <p class="section-overview--desktop">Maximising efficiency and flexibility with custom outsourcing</p> </a> </div> <div class="col-xl-3"> <a href="/insights/therapeutics-insights/oncology/de-risking-clinical-development-precision-medicines" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/a2f99da8-e333-4f57-8700-d1d3f72f301e/web/MDD_OncologyWhitepaper.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=4Jnst3Tp" width="260" height="136" alt="Oncology whitepaper web assets" loading="eager" title="Oncology whitepaper web assets" /> </div> </div> </div> <span class="h4">De-risking clinical development of precision medicines in oncology</span> <p class="section-overview--desktop">An evolving understanding of cancer biology has resulted in the rise of precision-informed treatment approaches.</p> </a> </div> <div class="col-xl-3"> <a href="/insights/value-based-healthcare/strategies-commercialising-oncology-treatments-young-adults" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/fa37bc49-7fc2-43b7-a5a7-22213c7da3b2/web/Oncology-youngadults_thumbnail_whitepaper.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=zl9MWidU" width="260" height="136" alt="Oncology-youngadults_thumbnail_whitepaper.jpg" loading="eager" title="Oncology-youngadults_thumbnail_whitepaper.jpg" /> </div> </div> </div> <span class="h4">Strategies for commercialising oncology treatments for young adults</span> <p class="section-overview--desktop">Oncology treatments tailored specifically for young adults.</p> </a> </div> </div> </div> </div> </li> <li class="nav-item dropdown"> <a href="/news-events" aria-expanded="false" class="nav-link dropdown-toggle" data-toggle="dropdown" role="button"> News &amp; Events <span></span> </a> <div class="menu_link_content menu-link-contentmain view-mode-main-navigation dropdown-menu"> <button class="navbar-btn navbar-btn--back" type="button"> <span class="navbar-btn__icon"></span> </button> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-xl-3"> <div class="paragraph paragraph--type--mega-menu-text paragraph--view-mode--default"> <div class="mega-menu-title"><span class="h4">News &amp; Events</span></div> <div class="section-overview--desktop"> <p>ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.</p> </div> <a class="dropdown-item section-overview--desktop" href="/news-events">Read more</a> </div> </div> <div class="col-xl-3"> <div class="mega-menu-title"> </div> <a href="/news-events/press-releases" class="dropdown-item" data-drupal-link-system-path="node/33789">Press releases</a> <a href="/news-events/thought-leadership" class="dropdown-item" data-drupal-link-system-path="node/34266">In the News</a> <a href="/news-events/mediakit" class="dropdown-item" data-drupal-link-system-path="node/33787">Mediakit</a> <a href="/news-events/awards" class="dropdown-item" data-drupal-link-system-path="node/33778">Awards</a> <a href="/news-events/events" class="dropdown-item" data-drupal-link-system-path="node/34258">Events</a> <a href="/news-events/events/webinars" class="dropdown-item" data-drupal-link-system-path="node/34260">Webinars</a> <a href="/news-events/social-media" class="dropdown-item" data-drupal-link-system-path="node/33790">Social media</a> </div> <div class="col-xl-3"> <a href="/news-events/events/webinars/s-stands-systematic-demystifying-systematic-literature-review" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/9a9accce-4155-444f-b063-33f4e93a91ed/web/digital_data_computer_MDD_300x157px.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=SYn4y_Yf" width="260" height="136" alt="digital_data_computer" loading="eager" title="digital_data_computer" /> </div> </div> </div> <span class="h4">“S” stands for systematic: Demystifying the systematic literature review</span> <p class="section-overview--desktop">5 December 2024</p> </a> </div> <div class="col-xl-3"> <a href="https://webinars.iconplc.com/detail/videos/clinical-research-services_/video/6363975248112/dosimetry-in-clinical-trials?autoStart=true" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/a2adec58-c2b5-4085-9b7f-09b42493f545/web/MDD_300x157.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=PtYs9Hjy" width="260" height="136" alt="dosimetry thumbnail" loading="eager" title="dosimetry thumbnail" /> </div> </div> </div> <span class="h4">Dosimetry in clinical trials</span> <p class="section-overview--desktop">Watch the recording</p> </a> </div> </div> </div> </div> </li> <li class="nav-item dropdown"> <a href="/about" aria-expanded="false" class="nav-link dropdown-toggle" data-toggle="dropdown" role="button"> About ICON <span></span> </a> <div class="menu_link_content menu-link-contentmain view-mode-main-navigation dropdown-menu"> <button class="navbar-btn navbar-btn--back" type="button"> <span class="navbar-btn__icon"></span> </button> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-xl-3"> <div class="paragraph paragraph--type--mega-menu-text paragraph--view-mode--default"> <div class="mega-menu-title"><a href="/about" target="_self">About ICON</a></div> </div> <a class="dropdown-item" href="/about/company-history">Company history</a> <a class="dropdown-item" href="/about/healthcare-intelligence">Healthcare Intelligence</a> <a class="dropdown-item" href="/about/icon-in-asia-pacific">ICON in Asia Pacific</a> <a class="dropdown-item" href="/about/icon-in-latin-america">ICON in Latin America</a> <a class="dropdown-item" href="/about/leadership">Leadership</a> <a class="dropdown-item" href="/about/quality">Quality</a> </div> <div class="col-xl-3"> <div class="mega-menu-title"> <div><span>ICON for</span></div> </div> <a href="https://www.accellacare.com/" target="_blank" class="dropdown-item">Patients</a> <a href="https://iconstudies.com/" target="_blank" class="dropdown-item">Volunteers</a> <a href="/investigators" class="dropdown-item" data-drupal-link-system-path="node/33762">Investigators</a> <a href="https://careers.iconplc.com/" target="_blank" class="dropdown-item">Jobs &amp; Careers</a> <a href="https://investor.iconplc.com/" target="_blank" class="dropdown-item">Investors</a> <a href="/about-icon/environmental-social-and-governance/governance/icon-suppliers" class="dropdown-item" data-drupal-link-system-path="node/33804">Suppliers</a> </div> <div class="col-xl-3"> <a href="/about/esg/" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/218ee692-1b56-4781-81ac-a5c21d998441/web/esg-mdd.jpg?crop=yes&amp;w=260&amp;h=136&amp;itok=4lb_pyzu" width="260" height="136" alt="esg-mdd.jpg" loading="eager" title="esg-mdd.jpg" /> </div> </div> </div> <span class="h4">Sustainability, diversity and charity</span> <p class="section-overview--desktop">ICON Cares is our commitment to making a positive impact on our people, environment and our community.</p> </a> </div> <div class="col-xl-3"> <a href="/about/clinical-research-evolved/" class="dropdown-item dropdown-item--with-image"> <div class="image image--zoom-on-hover"> <div><div><img src="https://icon.widen.net/content/731c8b9b-5eec-4227-903e-e4e1b9baf5a7/web/healthcare-intelligence-video-poster.png?crop=yes&amp;w=260&amp;h=136&amp;itok=7ocDsNRo" width="260" height="136" alt="healthcare-intelligence-video-poster.png" loading="eager" title="healthcare-intelligence-video-poster.png" /> </div> </div> </div> <span class="h4">Healthcare Intelligence</span> <p class="section-overview--desktop">Clinical Research. Evolved.</p> </a> </div> </div> </div> </div> </li> </ul> <ul region="primary_menu" class="navbar-nav navbar-nav-secondary"> <li class="nav-item"> <a href="https://careers.iconplc.com/" class="nav-link" target="_blank">Careers</a> </li> <li class="nav-item"> <a href="http://investor.iconplc.com/" class="nav-item-separator nav-link" target="_blank">Investors</a> </li> <li class="nav-item"> <a href="/contact" class="nav-item-separator nav-link" target="_self" data-drupal-link-system-path="node/33596">Contact</a> </li> <li class="nav-item"> <a href="https://iconplc.co.jp/" class="nav-link" target="_blank">日本語</a> </li> <li class="nav-item"> <a href="https://china.iconplc.com/" class="nav-link nav-item-separator" target="_blank">简体中文</a> </li> <li class="nav-item d-none d-xl-block"> <a class="nav-link" data-toggle="modal" href="#search-modal"> <i aria-hidden="true" class="icon-ui-search-loupe"></i> </a> </li> </ul> </div> <div class="navbar-revealer"></div> </div> <div class="navigation-backdrop fade"></div> </nav> </header> <div class="region region-highlighted"> <div data-drupal-messages-fallback class="hidden"></div> </div> <main role="main"> <a id="main-content" tabindex="-1"></a> <div class="layout-content"> <div class="region region-content"> <div id="block-iconplc-content"> <article> <div> <div class="layout layout--onecol"> <div class="layout__region layout__region--content"> <div id="6be354c3-ade3-4afb-ba9e-302dc97c0d99" class="promo--wrapper"> <div class="breadcrumb-wrapper "> <ol class="breadcrumb"> <li class="breadcrumb-item"> <a href="/" class="breadcrumb__link">Home</a> </li> <li class="breadcrumb-item"> <a href="/insights" class="breadcrumb__link">Insights</a> </li> <li class="breadcrumb-item"> <a href="/insights/therapeutics" class="breadcrumb__link">Therapeutics insights</a> </li> <li class="breadcrumb-item"> Cell and Gene Therapies </li> </ol> </div> <div> <div class="promo promo--subpage" data-title="Cell and Gene Therapies"> <div class="promo__content"> <div class="promo__image-overlay promo__image-overlay--purple"></div> <div title="Oncology" data-responsive-backgrounds="true" data-responsive-background-lg="https://icon.widen.net/content/5dbfc78c-98c0-4def-8c1f-f50e4ec46df8/web/cell-and-gene-ttherapy.jpg?crop=yes&amp;w=1920&amp;h=507&amp;a=0,0&amp;itok=wyl1jdk6" data-responsive-background-md="https://icon.widen.net/content/5dbfc78c-98c0-4def-8c1f-f50e4ec46df8/web/cell-and-gene-ttherapy.jpg?crop=yes&amp;w=1895&amp;h=600&amp;a=25,0&amp;itok=pi58o7Th" data-responsive-background-sm="https://icon.widen.net/content/5dbfc78c-98c0-4def-8c1f-f50e4ec46df8/web/cell-and-gene-ttherapy.jpg?crop=yes&amp;w=1566&amp;h=600&amp;a=354,0&amp;itok=VTBkZ765" data-responsive-background-xs="https://icon.widen.net/content/5dbfc78c-98c0-4def-8c1f-f50e4ec46df8/web/cell-and-gene-ttherapy.jpg?crop=yes&amp;w=402&amp;h=600&amp;a=1450,0&amp;itok=3X2mm84N" class="promo__image-container"></div> <div class="promo__text-container"> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-md-9"> <h1>Cell and Gene Therapies</h1> <p class="lead">Insights on delivering cell and gene clinical trials in multiple therapeutic areas based on lessons learned and best practices </p> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div class="layout layout--onecol"> <div class="layout__region layout__region--content"> <div id="f025fc5a-e4d6-4bc1-b910-7194fd8cb04b"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--picture-left-text-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6"> <div class="text-picture__picture"> <div class="text-picture-link-wrapper"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 1x, https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 1x, https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 1x, https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 1x, https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 1x, https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 1x, https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=106,0&amp;itok=uS3GRR7c 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/tzezgs1qf2/web/homepage%20banner_thumbnail_precision%20medicine_rare%20diseases_spotlight.jpg" width="1440" height="750" alt="precision medicine_rare diseases_spotlight_thumbnail" title="precision medicine_rare diseases_spotlight_thumbnail" loading="lazy" /> </picture> </div> </div> </div> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6"> <div class="text-picture__text"> <h2>Therapeutic spotlight: Precision medicine considerations in rare diseases</h2> <h3></h3> <div><p>In our latest therapeutic spotlight, ICON’s experts explore the evolving therapeutic landscape of precision medicine with a special focus on the unique application in ALS. We outline key considerations for developing patient-centric, streamlined precision medicine programs that promote patient engagement, improve protocol adherence and reduce dropout rates – ultimately accelerating the delivery of meaningful therapies to patients.</p></div> <a class="btn btn-primary btn-md" href="/insights/therapeutics-insights/rare-and-orphan-diseases/therapeutic-spotlight-precision-medicine" target="_self" title="Read more"> Read more </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="607ffca7-7736-4400-8908-f916f5f7196e"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--text-left-picture-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6 order-sm-2"> <div class="text-picture__picture"> <div class="text-picture-link-wrapper"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 1x, https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 1x, https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 1x, https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 1x, https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 1x, https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 1x, https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=2pwMAIco 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/t30daf3e9r/web/1110x678%20Landscape_OncologyWhitepaper.jpg" width="2221" height="1357" alt="Oncology whitepaper web assets" title="Oncology whitepaper web assets" loading="lazy" /> </picture> </div> </div> </div> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6 col-sm-pull-6"> <div class="text-picture__text"> <h2></h2> <h3>De-risking clinical development of precision medicines in oncology</h3> <div><p>This whitepaper reviews the most pressing challenges and opportunities facing the oncology therapeutic landscape in the emerging era of precision medicine, and reports on how those opportunities and challenges vary by organisational size and region.</p></div> <a class="btn btn-primary btn-md" href="/insights/therapeutics-insights/oncology/de-risking-clinical-development-precision-medicines" target="_self" title="Read the whitepaper"> Read the whitepaper </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="6850c40a-4825-49ed-8f11-87fbe45fadae"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--picture-left-text-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6"> <div class="text-picture__picture"> <div class="text-picture-link-wrapper"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 1x, https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 1x, https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 1x, https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 1x, https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 1x, https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 1x, https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg?crop=yes&amp;w=2048&amp;h=1251&amp;a=0,0&amp;itok=-vRbT2Ll 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/yjhrknuvkt/web/1110x678%20Landscape_OncologySurveyreport.jpg" width="2221" height="1357" alt="Oncology survey report web assets" title="Oncology survey report web assets" loading="lazy" /> </picture> </div> </div> </div> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6"> <div class="text-picture__text"> <h2></h2> <h3>ICON survey report: Innovation in oncology - Accelerating R&amp;D in an evolving landscape</h3> <div><p>In Spring of 2024, ICON conducted a survey of 104 professionals engaged in oncology drug development in North America and Europe, representing organisations ranging from small to large biotech and pharmaceutical companies.</p></div> <a class="btn btn-primary btn-md" href="https://www.iconplc.com/insights/therapeutics-insights/oncology/icon-survey-report-innovation-oncology" target="_self" title="Read the survey report"> Read the survey report </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="f441e8b0-b3e5-42f4-8994-f6f1db438e1e"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--text-left-picture-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6 order-sm-2"> <div class="text-picture__picture"> <div class="text-picture-link-wrapper"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 1x, https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 1x, https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 1x, https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 1x, https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 1x, https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 1x, https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=iXVRSq2V 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/ijrvapyrji/web/car-t-cell-whitepaper.jpg" width="555" height="339" alt="car-t-cell-whitepaper" title="car-t-cell-whitepaper" loading="lazy" /> </picture> </div> </div> </div> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6 col-sm-pull-6"> <div class="text-picture__text"> <h2></h2> <h3>Approaching the CAR T-cell therapy horizon</h3> <div> <p>Approved CAR T-cell therapies have shown remarkable results in patients with certain types of blood cancers, but further innovations are needed before the technology can reach its full potential. In this whitepaper, we explore the most exciting clinical developments in CAR T-cell therapy, and relate them to limitations of approved therapies.&nbsp;</p> </div> <a class="btn btn-primary btn-md" href="/insights/therapeutics/cell-and-gene-therapies/approaching-the-car-t-cell-therapy-horizon" target="_self" title="Read the whitepaper"> Read the whitepaper </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="05332aab-648b-4018-9e53-369c39f7fd92"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--picture-left-text-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6"> <div class="text-picture__picture"> <div class="text-picture-link-wrapper"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 1x, https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 1x, https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 1x, https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 1x, https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 1x, https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 1x, https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg?crop=yes&amp;w=1228&amp;h=750&amp;a=0,0&amp;itok=y_an-5IB 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/hicfb9c0lm/web/mainstreaming-CGT-banner-1440x750.jpg" width="1440" height="750" alt="mainstreaming-CGT-banner-1440x750" title="mainstreaming-CGT-banner-1440x750" loading="lazy" /> </picture> </div> </div> </div> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6"> <div class="text-picture__text"> <h2></h2> <h3>Mainstreaming Cell and Gene Therapies</h3> <div> <p>The cell and gene therapy (CGT) market is rapidly transitioning from ultra-niche cutting-edge science to approved and available therapies that can address previously intractable and often devastating diseases.</p> </div> <a class="btn btn-primary btn-md" href="/insights/therapeutics/cell-and-gene-therapies/mainstreaming-cell-gene-therapies" target="_self" title="Read the whitepaper"> Read the whitepaper </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="ad818407-dc60-44bf-ae63-d3635a367a04"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--text-left-picture-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6 order-sm-2"> <div class="text-picture__picture"> <div class="text-picture-link-wrapper"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 1x, https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 1x, https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 1x, https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 1x, https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 1x, https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 1x, https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=309,0&amp;itok=QdBAfhxN 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/yh1quyqlst/web/11921-CGT-Collateral-Subpage-Banner.jpg" width="1920" height="600" alt="11921-CGT-Collateral-Subpage-Banner" title="11921-CGT-Collateral-Subpage-Banner" loading="lazy" /> </picture> </div> </div> </div> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6 col-sm-pull-6"> <div class="text-picture__text"> <h2></h2> <h3>Long-term follow-up studies of cell and gene therapies</h3> <div> <p>Regulators typically expect that Sponsors collect up to 15 years of follow-up data on patients who’ve received cell and gene therapies either through a clinical trial or in clinical practice.</p> </div> <a class="btn btn-primary btn-md" href="/insights/therapeutics/cell-and-gene-therapies/long-term-follow-up-studies-of-cell-and-gene-therapies" target="_self" title="Read the whitepaper"> Read the whitepaper </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="401b8cf1-452e-479d-93ba-60cb1168d450"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--picture-left-text-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6"> <div class="text-picture__picture"> <div class="text-picture-link-wrapper"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 1x, https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 1x, https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 1x, https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 1x, https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 1x, https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 1x, https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg?crop=yes&amp;w=445&amp;h=272&amp;a=51,0&amp;itok=T_w87V6i 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/mstq5szg4y/web/Affordability.jpg" width="519" height="272" alt="Affordability" title="Affordability" loading="lazy" /> </picture> </div> </div> </div> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6"> <div class="text-picture__text"> <h2></h2> <h3>The affordability hurdle for gene therapies</h3> <div> <p>Until now US payers have absorbed and managed the cost of ultra-expensive therapies, but how long can they continue to do so? Read our whitepaper to understand the payer perspective on advanced therapy medicinal products.</p> </div> <a class="btn btn-primary btn-md" href="/insights/value-based-healthcare/the-affordability-hurdle-for-gene-therapies" target="_self" title="Read the whitepaper"> Read the whitepaper </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="eeb17309-446c-4522-8b3e-fbd359f1e9a6"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--text-left-picture-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6 order-sm-2"> <div class="text-picture__picture"> <a class="text-picture-link-wrapper" target="_top" href="/insights/therapeutics/cell-and-gene-therapies/cell-and-gene-therapy-clinical-trials"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 1x, https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 1x, https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 1x, https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 1x, https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 1x, https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 1x, https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg?crop=yes&amp;w=982&amp;h=600&amp;a=469,0&amp;itok=_X5jIoBx 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/rkt0uuxtrn/web/CGT-eBook_sub-page-banner.jpg" width="1920" height="600" alt="CGT-eBook_sub-page-banner" title="CGT-eBook_sub-page-banner" loading="lazy" /> </picture> </div> </div> </a> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6 col-sm-pull-6"> <div class="text-picture__text"> <h2>The promise and complexity of living therapies</h2> <h3></h3> <div> <p>As development of cell and gene therapies (CGT) accelerates, so will the demand for best practices, and better tools and solutions. For advanced therapies, the product and patient journey is entirely different from traditional trials. As such, biotech and pharma companies will need to overcome challenges and complexities from regulatory pathways and patient recruitment to logistics and manufacturing. Adopting strategic partnerships with deep CGT expertise with a broad spectrum of solutions and services is vital to the success of a development programme.</p> </div> <a class="btn btn-primary btn-md" href="/insights/therapeutics/cell-and-gene-therapies/cell-and-gene-therapy-clinical-trials" target="_self" title="Read the eBook"> Read the eBook </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="745bf591-3b46-4f73-b64a-66cf8bce02ee"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture text-left text-picture--picture-left-text-right text-left "> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="col-sm-6"> <div class="text-picture__picture"> <div class="text-picture-link-wrapper"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 1x, https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 2x" media="(min-width: 1400px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 1x, https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 2x" media="(min-width: 1200px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 1x, https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 2x" media="(min-width: 992px) and (max-width: 1199px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 1x, https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 2x" media="(min-width: 768px) and (max-width: 991px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 1x, https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 2x" media="(min-width: 576px) and (max-width: 767px)" width="555" height="339"/> <source srcset="https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 1x, https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg?crop=yes&amp;w=555&amp;h=339&amp;a=0,0&amp;itok=kVgdCUde 2x" media="(max-width: 575px)" width="555" height="339"/> <img src="https://icon.widen.net/content/jalddmtsd7/web/CGT-Podcast2.jpg" width="555" height="339" alt="CGT-Podcast2" title="CGT-Podcast2" loading="lazy" /> </picture> </div> </div> </div> </div> <div class="text-picture__picture-comment"> </div> </div> <div class="text-picture__text-wrapper col-sm-6"> <div class="text-picture__text"> <h2>Enabling clinical development of Cell and Gene Therapies on a global basis</h2> <h3></h3> <div> <p>ICON's CGT team share insights on best practices, custom resources and innovative tools for <a href="/insights/videos/#6152692081001" target="_self">enabling clinical development of cell and gene therapies on a global basis</a> in this BioInsights podcast (40 mins).</p> <p>Download the full transcript <a href="https://www2.iconplc.com/bio_insights_podcast" target="_self">here</a>.</p> </div> <a class="btn btn-primary btn-md" href="/insights/videos#6152692081001" target="_blank" title="Listen to podcast"> Listen to podcast </a> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div id="c7928efd-bb6e-470f-94db-3345474155c5"> <div class="group bg-transparent content-visibility--auto contain-intrinsic-size--400"> <div class="container-fluid container-fluid--xl"> <h2 class="group__title slick-carousel-title"> Cell and Gene Therapy clinical development webinars </h2> <div class="carousel--standard carousel--standard-1-3-4"> <a href="https://webinars.iconplc.com/detail/videos/laboratory-webinars/video/6318139487112/best-practices-for-laboratory-solutions-relating-to-cell-and-gene-therapy-clinical-trials?autoStart=true" class="block-link carousel__item" target="_self"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=299&amp;h=157&amp;a=1,0&amp;itok=sMc6WGNt 1x, https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=299&amp;h=157&amp;a=1,0&amp;itok=P-3eS5ab 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=299&amp;h=157&amp;a=1,0&amp;itok=sMc6WGNt 1x, https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=299&amp;h=157&amp;a=1,0&amp;itok=P-3eS5ab 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=299&amp;h=157&amp;a=1,0&amp;itok=sMc6WGNt 1x, https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=299&amp;h=157&amp;a=1,0&amp;itok=P-3eS5ab 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=299&amp;h=157&amp;a=1,0&amp;itok=7q-mvAzI 1x, https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=300&amp;h=83&amp;a=0,38&amp;itok=kCVPFuqY 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=300&amp;h=156&amp;a=0,1&amp;itok=jq88w5Px 1x, https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=300&amp;h=156&amp;a=0,1&amp;itok=Ps2DmA7g 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=PEX89Psv 1x, https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=300&amp;h=148&amp;a=0,5&amp;itok=0_vk08of 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/f7ukyeqhps/web/man-at-telescope.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=PEX89Psv" width="545" height="286" alt="man-at-telescope" title="man-at-telescope" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">Best practices for laboratory solutions relating to cell and gene therapy clinical trials</h4> <div class="card-text small"> <div> <p>In this webinar, we discuss factors to consider when executing CGT trials, illustrating how specialty molecular and flow cytometry approaches translate into best practices to support the unique patient, product, site, data and regulatory journeys.</p> </div> </div> </div> </div> </div> </a> <a href="https://webinars.iconplc.com/detail/videos/therapeutic-webinars/video/6276048320001/navigating-the-future-of-cell-gene-therapy---the-potential-for-broader-indication?autoStart=true" class="block-link carousel__item" target="_self"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=KZUcF1mW 1x, https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=0Fvne7bv 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=KZUcF1mW 1x, https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=0Fvne7bv 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=KZUcF1mW 1x, https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=0Fvne7bv 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=5DXv0beC 1x, https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=154&amp;a=0,93&amp;itok=6rIr3MxT 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=289&amp;a=0,26&amp;itok=sPH9LQxj 1x, https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=289&amp;a=0,26&amp;itok=-I9i99Mo 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=ABsZd3xt 1x, https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=555&amp;h=273&amp;a=0,34&amp;itok=1GGsBdl- 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/gxlcx2vjhm/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=ABsZd3xt" width="545" height="286" alt="12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1" title="12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-1" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">Navigating the future of CGT: The potential for broader indication</h4> <div class="card-text small"> <div> <p>This roundtable will explore the significant opportunities and challenges posed by CGT clinical trials, and how a CRO partner may be uniquely placed to help a pharma innovator navigate them.</p> </div> </div> </div> </div> </div> </a> <a href="https://webinars.iconplc.com/detail/videos/therapeutic-webinars/video/6276048057001/the-importance-of-early-planning-in-cell-gene-therapy-commercialization?autoStart=true" class="block-link carousel__item" target="_self"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=etCryUKx 1x, https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=rRKWZXC7 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=etCryUKx 1x, https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=rRKWZXC7 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=etCryUKx 1x, https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=rRKWZXC7 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=rvoKRJm4 1x, https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=154&amp;a=0,93&amp;itok=zyp27Yjw 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=289&amp;a=0,26&amp;itok=L2sdlsdQ 1x, https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=289&amp;a=0,26&amp;itok=-MXdo5H2 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=LUZRlbKw 1x, https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=555&amp;h=273&amp;a=0,34&amp;itok=3OwbCPmO 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/ryxli7epqv/web/12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=LUZRlbKw" width="545" height="286" alt="12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2" title="12262-023_Cell-and-gene-therapy-webinar_Insights-Articles-2" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">The importance of early planning in CGT commercialisation</h4> <div class="card-text small"> <div> <p>This roundtable will identify successful strategies that underpin currently-marketed therapies and examine how establishing a framework early in development helps keep long-term production and commercialisation goals on track.</p> </div> </div> </div> </div> </div> </a> <a href="https://webinars.iconplc.com/detail/videos/therapeutic-webinars/video/6276048507001/implementing-novel-development-strategies-for-cell-gene-therapy-clinical-trials?autoStart=true" class="block-link carousel__item" target="_self"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=1Ldqilsf 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=tpaB2Qj2 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=1Ldqilsf 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=tpaB2Qj2 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=1Ldqilsf 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=tpaB2Qj2 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=QQ0v1G84 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=103&amp;a=0,46&amp;itok=P_I2HkGc 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=192&amp;a=0,1&amp;itok=Xo_LiEZB 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=192&amp;a=0,1&amp;itok=b_16sMoL 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=yCtAPl_K 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=182&amp;a=0,6&amp;itok=vGuANQ0d 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=yCtAPl_K" width="545" height="286" alt="cell-and-gene-therapeutics" title="cell-and-gene-therapeutics" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">Implementing novel development strategies for CGT clinical trials</h4> <div class="card-text small"> <div> <p>This roundtable will review the necessary considerations and logistics of conducting CGT trials, and how sponsors and service providers can optimize their clinical research to maximize the prospect of success.</p> </div> </div> </div> </div> </div> </a> <a href="https://webinars.iconplc.com/detail/videos/therapeutic-webinars/video/6276183716001/the-changing-face-of-cell-and-gene-therapy-impacts-on-planning-and-executing-trials?autoStart=true" class="block-link carousel__item" target="_blank"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=f9XTzf_c 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=fkg2G9sQ 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=f9XTzf_c 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=fkg2G9sQ 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=f9XTzf_c 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=fkg2G9sQ 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1429&amp;h=750&amp;a=6,0&amp;itok=uW9beGx2 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1440&amp;h=400&amp;a=0,175&amp;itok=0V3dQnVw 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1440&amp;h=749&amp;a=0,1&amp;itok=SnP4hvoO 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1440&amp;h=749&amp;a=0,1&amp;itok=lYM0FJGq 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=kFb9zFpI 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1440&amp;h=708&amp;a=0,21&amp;itok=v5cH24qC 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=kFb9zFpI" width="545" height="286" alt="12132_Oncology-Webinar_landing-page-banner" title="12132_Oncology-Webinar_landing-page-banner" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">The changing face of cell and gene therapy</h4> <div class="card-text small"> <div> <p>Considerable strides have been made in the development of cell and gene therapies since the first autologous CAR T therapy was approved by the FDA four years ago.</p> </div> </div> </div> </div> </div> </a> <a href="http://webinars.iconplc.com/detail/videos/therapeutic-webinars/video/6264736756001/webinar:-designing-and-conducting-effective-long-term-follow-up-studies?autoStart=true" class="block-link carousel__item" target="_self"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=iIeXtfc5 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=JmHsnnPm 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=iIeXtfc5 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=JmHsnnPm 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=iIeXtfc5 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=292&amp;a=0,24&amp;itok=JmHsnnPm 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=EIVZdClC 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=154&amp;a=0,93&amp;itok=dk5Lrz94 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=289&amp;a=0,26&amp;itok=iAnjnWAR 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=289&amp;a=0,26&amp;itok=0VIadhgi 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=545&amp;h=286&amp;itok=tetwzeBU 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=273&amp;a=0,34&amp;itok=rd-APFyD 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=545&amp;h=286&amp;itok=tetwzeBU" width="545" height="286" alt="11921-CGT-Collateral-Insights" title="11921-CGT-Collateral-Insights" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">Designing and conducting effective long term follow-up studies</h4> <div class="card-text small"> <div> <p>New regulatory requirements have sparked more interest in stand-alone long-term follow up studies for monitoring patient outcomes and safety.</p> </div> </div> </div> </div> </div> </a> <a href="/news-events/events/webinars/isct-patient-advocacy" class="block-link carousel__item" target="_self"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=_rD2mpdB 1x, https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=eAo5nOXG 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=_rD2mpdB 1x, https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=eAo5nOXG 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=_rD2mpdB 1x, https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=369&amp;h=194&amp;a=1,0&amp;itok=eAo5nOXG 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=WTyu_uYq 1x, https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=370&amp;h=103&amp;a=0,46&amp;itok=ocKXotH0 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=370&amp;h=192&amp;a=0,1&amp;itok=voaRmBdb 1x, https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=370&amp;h=192&amp;a=0,1&amp;itok=IRNz2WoT 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=Y_UJ60UJ 1x, https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=370&amp;h=182&amp;a=0,6&amp;itok=qiyC9CBu 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/f6evqdgigc/web/isct-cell-and-gene-webinar-card.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=Y_UJ60UJ" width="545" height="286" alt="isct-cell-and-gene-webinar-card" title="isct-cell-and-gene-webinar-card" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">Patient advocacy and access to innovative clinical trials in a changed environment (COVID-19)</h4> <div class="card-text small"> <div> <p>Working with “living therapies” during COVID-19 has changed access, resource planning and management in CGT trials.</p> </div> </div> </div> </div> </div> </a> <a href="http://webinars.iconplc.com/detail/videos/commercialisation-outcomes/video/6215146941001/hta-and-market-access-implications-for-gene-therapies-learnings-for-future-products?autoStart=true" class="block-link carousel__item" target="_blank"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=KlrkEb8m 1x, https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=3BNkBipN 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=KlrkEb8m 1x, https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=3BNkBipN 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=KlrkEb8m 1x, https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1426&amp;h=750&amp;a=7,0&amp;itok=3BNkBipN 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1429&amp;h=750&amp;a=6,0&amp;itok=hU3WeIxu 1x, https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1440&amp;h=400&amp;a=0,175&amp;itok=TgiDYwT2 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1440&amp;h=749&amp;a=0,1&amp;itok=gpSbp4mB 1x, https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1440&amp;h=749&amp;a=0,1&amp;itok=HHdB9diO 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=N9DMUOcm 1x, https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=1440&amp;h=708&amp;a=0,21&amp;itok=bGPyJIV3 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/xtveztuxug/web/11398_ATMPsHTAPricing_HBanner_1440x750.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=N9DMUOcm" width="545" height="286" alt="11398_ATMPsHTAPricing_HBanner_1440x750" title="11398_ATMPsHTAPricing_HBanner_1440x750" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">HTA and market access implications for gene therapies</h4> <div class="card-text small"> <div> <p>A key challenge for manufacturers is to demonstrate value to payers in a health technology assessment (HTA) setting.</p> </div> </div> </div> </div> </div> </a> <a href="http://webinars.iconplc.com/detail/videos/therapeutic-webinars/video/6196343459001/webinar:-achieving-quality-cell-and-gene-therapies-outcomes-through-multidisciplinary-collaboration?autoStart=true" class="block-link carousel__item" target="_blank"> <div class="container-full"> <div class="card card--standard bg-white text-left"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1141&amp;h=600&amp;a=390,0&amp;itok=aKo3C9ks 1x, https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1141&amp;h=600&amp;a=390,0&amp;itok=OXP9QvCP 2x" media="(min-width: 1400px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1141&amp;h=600&amp;a=390,0&amp;itok=aKo3C9ks 1x, https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1141&amp;h=600&amp;a=390,0&amp;itok=OXP9QvCP 2x" media="(min-width: 1200px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1141&amp;h=600&amp;a=390,0&amp;itok=aKo3C9ks 1x, https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1141&amp;h=600&amp;a=390,0&amp;itok=OXP9QvCP 2x" media="(min-width: 992px) and (max-width: 1199px)" width="270" height="142"/> <source srcset="https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1144&amp;h=600&amp;a=388,0&amp;itok=jMy-6E3n 1x, https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1920&amp;h=533&amp;a=0,34&amp;itok=tqCY_B7K 2x" media="(min-width: 768px) and (max-width: 991px)" width="162" height="85"/> <source srcset="https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1154&amp;h=600&amp;a=383,0&amp;itok=YtI0K0rU 1x, https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1154&amp;h=600&amp;a=383,0&amp;itok=6gWsblvB 2x" media="(min-width: 576px) and (max-width: 767px)" width="100" height="52"/> <source srcset="https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=tqLxBUoO 1x, https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=1220&amp;h=600&amp;a=350,0&amp;itok=_MQud03B 2x" media="(max-width: 575px)" width="545" height="286"/> <img class="card-img-top rounded-0" src="https://icon.widen.net/content/ebb9go058q/web/CGT-webinar_Sub_Landing-Page-banner.jpg?crop=yes&amp;w=545&amp;h=286&amp;itok=tqLxBUoO" width="545" height="286" alt="CGT-webinar_Sub_Landing-Page-banner" title="CGT-webinar_Sub_Landing-Page-banner" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body"> <h4 class="card-title">Achieving quality cell and gene therapies outcomes through multidisciplinary collaboration</h4> <div class="card-text small"> <div> <p>Explore how cell and gene therapy related experience can promote quality of data and higher patient accrual.</p> </div> </div> </div> </div> </div> </a> </div> </div> </div> </div> <div id="fd7a1c50-ae5e-4fa6-b425-2505dab625df"> <div class="group bg-white"> <div class="container-fluid container-fluid--xl"> <h2 class="group__title"> Cell and Gene Therapy blogs and media contributions </h2> <p class="group__text"> </p> <ul class="row card-list"> <li> <a href="https://www.thepharmaletter.com/survey-shows-varied-views-on-impact-of-new-cancer-drugs" class="block-link" target="_blank"> <div class="card card--overlapping-img card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <img src="https://icon.widen.net/content/gpgehkarfd/original/Survey-shows_oncology_landscape-hero_LARGE.jpg?u=b6mswy" alt="oncology survey thumbnail" title="oncology survey thumbnail" /> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Survey shows varied views on impact of new cancer drugs</h4> <div class="card-text small"> <div><p>This article published in The Pharma Letter highlights findings from an ICON survey has found that despite the increasing investment in emerging oncology-related therapeutics, developers have varied views on the impact of new cancer drugs for patients.</p></div> </div> </div> </div> </a> </li> <li> <a href="https://www.precisionmedicineonline.com/precision-oncology/biomarker-identification-challenge-and-opportunity-cancer-drug-development" class="block-link" target="_blank"> <div class="card card--overlapping-img card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <img src="https://icon.widen.net/content/cicyhtsifo/original/Precision-Medicine_Media-article_2024_1110x678_article.jpg?u=b6mswy" alt="precision medicine article thumbnail" title="precision medicine article thumbnail" /> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Biomarker Identification a Challenge and Opportunity in Cancer Drug Development, Survey Finds</h4> <div class="card-text small"> <div><p>This news piece from Precision Medicine Online provides an overview of the findings from ICON’s recent survey of professionals engaged in oncology-related clinical research.. It shares respondents' insights on how precision medicine approaches are changing development strategies and the to the extent these therapeutic advances will benefit patients in the future.</p></div> </div> </div> </div> </a> </li> <li> <a href="https://www.europeanpharmaceuticalreview.com/article/228833/pharma-horizons-cell-and-gene-therapy/" class="block-link" target="_blank"> <div class="card card--overlapping-img card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <img src="https://icon.widen.net/content/aim87y7ksy/original/CGT-cell-and-gene-article-thumbnail.jpg?u=z8skf3" alt="CGT-cell and gene-article-thumbnail" title="CGT-cell and gene-article-thumbnail" /> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Pharma Horizons: Cell and Gene Therapy</h4> <div class="card-text small"> <div><p>In this report, experts in the field including ICON's Patricia Fox Anderson and Emily Merrell explore some of the latest innovations in the cell and gene therapy space, from development and quality control, through to manufacturing and clinical trials.</p></div> </div> </div> </div> </a> </li> <li> <a href="https://www.biospectrumasia.com/opinion/122/24016/engineering-car-t-cell-sharpshooters.html" class="block-link" target="_blank"> <div class="card card--overlapping-img card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <img src="https://icon.widen.net/content/epblpzlj4p/original/BioSpectrum-Asia-Article-car-t-oncology-cgt-MDD.png?u=mvwkap" alt="BioSpectrum Asia Article-car-t-oncology-cgt-MDD" title="BioSpectrum Asia Article-car-t-oncology-cgt-MDD" /> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Engineering CAR T-cell sharpshooters</h4> <div class="card-text small"> <div><p>In this article, ICON's Brian Huber explains why and discusses the prospects for the next-generation of CAR T-cell therapies engineered to be more adaptable, precise and controlled.</p></div> </div> </div> </div> </a> </li> <li> <a href="https://icon.widen.net/s/qpzcf8mvkp/cgt-ife-cycle-management---meeting-on-the-mesa-2023-roundtable" class="block-link" target="_blank"> <div class="card card--overlapping-img card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <img src="https://icon.widen.net/content/sfs5xr6omt/original/ICON-Bioanalytical-Laboratories.jpg?u=z8skf3" alt="ICON-Bioanalytical-Laboratories" title="ICON-Bioanalytical-Laboratories" /> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Lifecycle management for CGTs: Solving operational challenges in an expanding market</h4> <div class="card-text small"> <div><p>The development of cell and gene therapies (CGTs), such as CAR T-cells and autologous and allogeneic therapies, is gaining momentum. To deliver these cures to patients with unmet needs, life sciences companies must navigate clinical trials—a process that is more complex for CGTs than for small molecules.</p></div> </div> </div> </div> </a> </li> <li> <a href="https://www2.iconplc.com/media-article-clinical-supplies-management-clinical-research-news-january-2024" class="block-link" target="_blank"> <div class="card card--overlapping-img card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <img src="https://icon.widen.net/content/nl9zcpirz7/original/cell-and-gene-therapy-trials.jpg?u=z8skf3" alt="cell-and-gene-therapy-trials" title="cell-and-gene-therapy-trials" /> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Practical Considerations for Managing CGT Supply Chains</h4> <div class="card-text small"> <div><p>More than in traditional trials, the unique manufacturing process and logistical complexity of CGTs require intense resource allocation, meticulous planning and rigorous controls. In this article, we outline practical considerations for managing your CGT supply chain to minimize risk, mitigate cost, and complexity.</p></div> </div> </div> </div> </a> </li> <li> <a href="https://international-biopharma.com/innovative-laboratory-testing-methods-for-clinical-monitoring-of-cell-therapies-using-flow-cytometry-ddpcr-and-qpcr-assays/" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1144&amp;h=600&amp;a=571,0&amp;itok=968IwjTd 1x, https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1144&amp;h=600&amp;a=571,0&amp;itok=_pSrThTv 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1144&amp;h=600&amp;a=571,0&amp;itok=968IwjTd 1x, https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1144&amp;h=600&amp;a=571,0&amp;itok=_pSrThTv 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1143&amp;h=600&amp;a=572,0&amp;itok=2NZjvQVs 1x, https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=868&amp;h=600&amp;a=709,0&amp;itok=EQZlwdSj 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1149&amp;h=600&amp;a=569,0&amp;itok=TTSeAVd5 1x, https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1149&amp;h=600&amp;a=569,0&amp;itok=OFTJ7r5r 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1143&amp;h=600&amp;a=572,0&amp;itok=VRX93PGo 1x, https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1143&amp;h=600&amp;a=572,0&amp;itok=hUQ9QfFb 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1143&amp;h=600&amp;a=572,0&amp;itok=MZyFRqUV 1x, https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1143&amp;h=600&amp;a=572,0&amp;itok=W9ezavWv 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/fehxeyeaxk/web/laboratories.jpg?crop=yes&amp;w=1143&amp;h=600&amp;a=572,0&amp;itok=MZyFRqUV" width="400" height="210" alt="laboratories" title="laboratories" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Innovative laboratory testing methods for clinical monitoring of cell therapies using flow cytometry DDPCR and QPCR assays</h4> <div class="card-text small"> <div> <p>This article explores how&nbsp;unique applications of PCR and flow cytometry&nbsp;can be used to provide critical and complementary data that is needed to bring&nbsp;new life-saving treatment options to patients.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.biopharminternational.com/view/logistical-considerations-in-mrna-vaccine-development" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=V3b7UVE1 1x, https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=1aGs44ej 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=V3b7UVE1 1x, https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=1aGs44ej 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=uReKn9XK 1x, https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=491&amp;h=339&amp;a=64,0&amp;itok=YqeVdNAP 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=290&amp;a=0,0&amp;itok=2lZDa0v5 1x, https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=290&amp;a=0,0&amp;itok=YQpmLqly 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=7tjZ5SyX 1x, https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=uvJRLCdz 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=uMcwRhBr 1x, https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=21WA736g 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/awrdloqtul/web/Vaccines-Covid-19_picture_componant.jpg?crop=yes&amp;w=555&amp;h=291&amp;a=0,0&amp;itok=uMcwRhBr" width="400" height="210" alt="Vaccines-Covid-19_picture_componant" title="Vaccines-Covid-19_picture_componant" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Logistical considerations in mRNA vaccine development</h4> <div class="card-text small"> <div> <p>In this article, ICON’s Andreas Dreps and Martin Lachs discuss the logistical considerations in&nbsp;mRNA vaccine development.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.biopharminternational.com/view/challenges-of-expanding-car-t-cell-therapy-into-solid-tumors" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=DEQI5oxD 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=mZ7YebXY 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=DEQI5oxD 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=mZ7YebXY 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=xNiyEGz5 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=491&amp;h=339&amp;a=33,0&amp;itok=bkyGDV9T 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=290&amp;a=0,25&amp;itok=cHHTJGnV 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=290&amp;a=0,25&amp;itok=DDIIjFWM 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=iwjFJJky 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=UL9qA_M9 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=3ngqNzY6 1x, https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=0bILB_5r 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/n5fcflaubw/web/11921-CGT-Collateral-Insights.png?crop=yes&amp;w=555&amp;h=291&amp;a=0,25&amp;itok=3ngqNzY6" width="400" height="210" alt="11921-CGT-Collateral-Insights" title="11921-CGT-Collateral-Insights" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Challenges of expanding CAR-T Cell Therapy into solid tumors</h4> <div class="card-text small"> <div> <p>Learn more about the&nbsp;challenges associated with developing CAR-T therapies for solid tumors&nbsp;in this article.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.biopharmadive.com/spons/mainstreaming-cell-and-gene-therapy-realizing-its-potential/637011/" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=cXR1i3fJ 1x, https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=MQBpMkwf 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=cXR1i3fJ 1x, https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=MQBpMkwf 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=nJFPqOR3 1x, https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=492&amp;h=340&amp;a=18,0&amp;itok=wch-E8li 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=281&amp;a=0,0&amp;itok=QFnR_GSf 1x, https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=281&amp;a=0,0&amp;itok=fV-nhmwD 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=1bmwNNOU 1x, https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=daSPQKQ7 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=7UUvp_9V 1x, https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=UyYCcRKA 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/fxohs1vhj9/web/DNA-helix.jpg?crop=yes&amp;w=539&amp;h=283&amp;a=0,0&amp;itok=7UUvp_9V" width="400" height="210" alt="DNA-helix" title="DNA-helix" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Mainstreaming cell and gene therapy – Realizing its potential</h4> <div class="card-text small"> <div> <p>This article looks at the&nbsp;Cell and gene therapies (CGT) landscape, the challenges biopharma companies face in running clinical trials and tips on how to surmount those obstacles.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.pmlive.com/pme#/reader/46667/174091" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=eST54r5d 1x, https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=bk95-b7m 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=eST54r5d 1x, https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=bk95-b7m 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=hiPIzrTn 1x, https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=313&amp;a=0,0&amp;itok=slNIffwK 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=237&amp;a=0,17&amp;itok=IK4jBKgo 1x, https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=237&amp;a=0,17&amp;itok=kzctG5Wk 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=-OU6JmD4 1x, https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=iGsNwX_R 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=4CdgqUXh 1x, https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=7qeuETsk 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/fvwze0hysw/web/Oncology-cells_1.jpg?crop=yes&amp;w=453&amp;h=238&amp;a=0,16&amp;itok=4CdgqUXh" width="400" height="210" alt="Oncology-cells_1" title="Oncology-cells_1" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: CAR-T cell therapy in oncology</h4> <div class="card-text small"> <div> <p>In this article,&nbsp;Brian Huber&nbsp;and&nbsp;Tamie Joeckel,&nbsp;consider how cell and gene therapies could change the future of cancer treatments and bring new options to patients.</p> </div> </div> </div> </div> </a> </li> <li> <a href="/insights/blog/2022/10/06/navigating-complex-cgt-clinical-trial-design" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=HYoG6VWi 1x, https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=KZuQR-Sk 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=HYoG6VWi 1x, https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=KZuQR-Sk 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=vFGjD7ZS 1x, https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=117&amp;a=0,27&amp;itok=rl79TtQb 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=9fbgig-v 1x, https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=yoJYELdC 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=wFzQzNzJ 1x, https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=Bi3KCdzL 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=tI_RLH5V 1x, https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=wXopAkJn 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/z58hgmovdy/web/13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail.jpg?crop=yes&amp;w=170&amp;h=89&amp;a=0,41&amp;itok=tI_RLH5V" width="400" height="210" alt="13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail" title="13244-029-Mainstreaming-cell-and-gene-therapies-blog-thumbnail" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Blog: Navigating the complexity of CGT clinical trial design</h4> <div class="card-text small"> <div> <p>This blog will explore some of the challenges of CGT clinical trial design, such as patient recruitment and data collection, and strategies for how to approach them.&nbsp;</p> </div> </div> </div> </div> </a> </li> <li> <a href="/insights/blog/2022/09/19/clinical-development-challenges" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1144&amp;h=600&amp;a=388,0&amp;itok=w_WoLHdx 1x, https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1144&amp;h=600&amp;a=388,0&amp;itok=0UJjJ0uT 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1144&amp;h=600&amp;a=388,0&amp;itok=w_WoLHdx 1x, https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1144&amp;h=600&amp;a=388,0&amp;itok=0UJjJ0uT 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1143&amp;h=600&amp;a=389,0&amp;itok=dTX5viON 1x, https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=868&amp;h=600&amp;a=526,0&amp;itok=9ETVgEqa 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1149&amp;h=600&amp;a=386,0&amp;itok=nRDptT0u 1x, https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1149&amp;h=600&amp;a=386,0&amp;itok=dK025h3z 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1143&amp;h=600&amp;a=389,0&amp;itok=ZqMap7Op 1x, https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1143&amp;h=600&amp;a=389,0&amp;itok=6JupZnYV 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1143&amp;h=600&amp;a=389,0&amp;itok=M-9JZyMI 1x, https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1143&amp;h=600&amp;a=389,0&amp;itok=gQfRlvDJ 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/tvzd4po2i2/web/12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2.png?crop=yes&amp;w=1143&amp;h=600&amp;a=389,0&amp;itok=M-9JZyMI" width="400" height="210" alt="12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2" title="12351-Advanced-therapies-for-rare-diseases_Landing-Page_v3.2" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Blog: Clinical development challenges faced by advanced therapies for rare disease</h4> <div class="card-text small"> <div> <p>Advanced therapies are a class of products based on genes, tissues or cells used to treat or deliver treatment to patients.</p> </div> </div> </div> </div> </a> </li> <li> <a href="http://www.sourcegrouppublication.com/books/viyn/#p=1" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1430&amp;h=750&amp;a=5,0&amp;itok=A06u0b_6 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1430&amp;h=750&amp;a=5,0&amp;itok=bga8G8BX 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1430&amp;h=750&amp;a=5,0&amp;itok=A06u0b_6 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1430&amp;h=750&amp;a=5,0&amp;itok=bga8G8BX 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1429&amp;h=750&amp;a=6,0&amp;itok=aOZD2M03 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1085&amp;h=750&amp;a=178,0&amp;itok=pxSajak3 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1436&amp;h=750&amp;a=2,0&amp;itok=e00aYmbj 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1436&amp;h=750&amp;a=2,0&amp;itok=6A6e-NTS 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1429&amp;h=750&amp;a=6,0&amp;itok=GqSLVGvH 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1429&amp;h=750&amp;a=6,0&amp;itok=Mfl6LSbB 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1429&amp;h=750&amp;a=6,0&amp;itok=QL20GARH 1x, https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1429&amp;h=750&amp;a=6,0&amp;itok=RNrYxFQM 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/0mk60dbmpk/web/12132_Oncology-Webinar_landing-page-banner.jpg?crop=yes&amp;w=1429&amp;h=750&amp;a=6,0&amp;itok=QL20GARH" width="400" height="210" alt="12132_Oncology-Webinar_landing-page-banner" title="12132_Oncology-Webinar_landing-page-banner" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Cell and gene therapy specific market authorisation guidances</h4> <div class="card-text small"> <div> <p>Brandon Fletcher offers his insights on&nbsp;the key changes in regulatory guidance documents released by the US Food and Drug Agency.</p> </div> </div> </div> </div> </a> </li> <li> <a href="/insights/blog/2022/05/26/cell-and-gene-therapy-specific-market-authorisation-guidances" class="block-link" target="_self"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=UKZreP7Z 1x, https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=CQVX9WQt 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=UKZreP7Z 1x, https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=CQVX9WQt 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=TykgzjPG 1x, https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=138&amp;a=0,31&amp;itok=cpVrWJ0M 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=104&amp;a=0,48&amp;itok=RgqzsQNo 1x, https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=104&amp;a=0,48&amp;itok=9oDupBUE 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=A5UUr-fP 1x, https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=KTSr6twz 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=Y0OmxMe2 1x, https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=4b-Ad769 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/q4m6psqh2r/web/Cell-and-Gene-Therapy-Image-200x200.jpg?crop=yes&amp;w=200&amp;h=105&amp;a=0,48&amp;itok=Y0OmxMe2" width="400" height="210" alt="Cell-and-Gene-Therapy-Image-200x200" title="Cell-and-Gene-Therapy-Image-200x200" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Blog: Cell and Gene Therapy: Specific Market Authorisation Guidances</h4> <div class="card-text small"> <div> <p>Therapeutic developers may benefit from working with a partner whose regulatory expertise with CGTs will help ensure that development programmes are optimal and compliant.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.pmlive.com/pme#/reader/43171/136868" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=Jh_J7HZw 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=MT5Q_X3P 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=Jh_J7HZw 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=MT5Q_X3P 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=9MuQy8Yw 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=RrM9ym_J 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=5sK-CvfO 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=N3nc9dgV 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=-PZDHvdy 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=_FB_cRJP 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=0kt5ezLt 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=KHectx_7 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=0kt5ezLt" width="400" height="210" alt="cell-and-gene-therapy-iconography" title="cell-and-gene-therapy-iconography" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Gene therapy – affordability, access and reimbursement</h4> <div class="card-text small"> <div> <p>Brian Huber considers&nbsp;the affordability, access and reimbursement challenges within the gene therapy market.<br> <br> </p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.pharmaceutical-technology.com/features/icon-talking-affordability-cell-and-gene-therapies/" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=J74cVY6N 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=DvPIn9b9 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=J74cVY6N 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=DvPIn9b9 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=J3jYJSg2 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=256&amp;a=0,57&amp;itok=KJ-ABcBG 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,89&amp;itok=8r8bk7n5 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,89&amp;itok=7nNbPfNe 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=B8v0__w3 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=2_9qQadQ 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=HfL8xjvg 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=PRirXtpP 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=HfL8xjvg" width="400" height="210" alt="oncology-tumor" title="oncology-tumor" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: ICON Q&amp;A - talking affordability in cell and gene therapies</h4> <div class="card-text small"> <div> <p>Tamie Joeckel discusses the challenges of making cell and gene therapies affordable for payers and patients alike.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://en.calameo.com/read/0061133856994069c873f?page=16" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=uzhm8Z7s 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=_H42ZIYZ 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=uzhm8Z7s 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=_H42ZIYZ 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=bMPflhcN 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=enmbP58X 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=c4s9xwdP 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=IsIbSwZB 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=WXRpmfjW 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=iLcQjPGn 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=edI-wBgU 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=GNb18Hu2 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=edI-wBgU" width="400" height="210" alt="cell-and-gene-therapeutics" title="cell-and-gene-therapeutics" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: The new oncology: What makes CGT cancer trials different</h4> <div class="card-text small"> <div> <p>Brandon Fletcher, CGT Principal, discusses how oncology is adapting to cell and gene therapy, and what can be done to improve take-up across the industry.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.oncology-central.com/overcoming-data-flow-challenges-in-cell-therapy-trials-an-interview-with-olivier-saulin/" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=Q6NOn7kC 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=mOMUtfwO 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=Q6NOn7kC 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=mOMUtfwO 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=jSOV3vK0 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=2n5DDMiy 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=e7K3JpcH 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=BDyMhlgl 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=Vs4BHp3C 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=ibHRiZOo 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=zb5xp-v6 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=qvFGQUyS 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=zb5xp-v6" width="400" height="210" alt="cells-in-gene-therapy" title="cells-in-gene-therapy" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Overcoming data flow challenges in cell therapy trials</h4> <div class="card-text small"> <div> <p>How data flows in cell therapy studies differ from other studies and strategies to manage the high volume of data in CGT trials is highlighted in this Q&amp;A with ICON expert Olivier Saulin.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://deep-dive.pharmaphorum.com/magazine/oncology-2021/lessons-from-the-first-generation-of-cell-gene-oncology-trials/" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=RkpPBuAf 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=h2pJItFt 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=RkpPBuAf 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=h2pJItFt 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=9e4V0RQD 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=byZ3wrn3 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=ainSnf6W 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=f_Lz7fC6 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=wqa-NmhD 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=hyals1r2 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=91xeLl6o 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=ZAgoJ5Oa 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=91xeLl6o" width="400" height="210" alt="cell-gene-therapy-image" title="cell-gene-therapy-image" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Lessons from the first generation of cell and gene oncology trials</h4> <div class="card-text small"> <div> <p>A discussion on best-practice approaches to CGT studies and what the future could hold for this exciting area.</p> </div> </div> </div> </div> </a> </li> <li> <a href="/insights/blog/2021/03/20/navigating-complexity-of-cell-therapy-during-the-covid19-pandemic" class="block-link" target="_self"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=cz0QIoaZ 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=kE7p6uRk 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=cz0QIoaZ 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=kE7p6uRk 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=S3USfsJr 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=RPhUMzMc 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=mOPATxgx 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=XUHfYrfQ 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=GxxMiF_Y 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=kTLZi5yj 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=kGKuyExj 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=NytwAXSF 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=kGKuyExj" width="400" height="210" alt="cell-gene-therapy-blue-image" title="cell-gene-therapy-blue-image" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Blog: Navigating complexity of cell therapy manufacturing during the COVID-19 pandemic</h4> <div class="card-text small"> <div> <p>Over the past year, the COVID-19 pandemic significantly disrupted clinical research across the lifecycle including recruitment challenges, protocol amendments and delayed market entry.</p> </div> </div> </div> </div> </a> </li> <li> <a href="/insights/blog/2021/03/16/navigating-complexity-in-oncology-cell-and-gene-therapy-clinical-trials" class="block-link" target="_self"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=d7HHInon 1x, https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=NxfHlxNS 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=d7HHInon 1x, https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=NxfHlxNS 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=7k_togrz 1x, https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=256&amp;a=0,79&amp;itok=c7vPFScu 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,111&amp;itok=0LfNssWY 1x, https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,111&amp;itok=HMekoV_l 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=e8Q81CtG 1x, https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=1wYZG03I 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=l_Tzx5kB 1x, https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=AhX036dK 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/gvb3gh5pqa/web/oncology_cells.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,110&amp;itok=l_Tzx5kB" width="400" height="210" alt="oncology_cells" title="oncology_cells" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Blog: Navigating complexity in oncology cell and gene therapy clinical trials</h4> <div class="card-text small"> <div> <p>Cell and gene therapies (CGT) are playing an increasingly important role in treating oncology patients.</p> </div> </div> </div> </div> </a> </li> <li> <a href="/insights/blog/2021/03/24/cell-and-gene-therapy-trials" class="block-link" target="_self"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1074&amp;a=0,231&amp;itok=K1QxWY-I 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1074&amp;a=0,231&amp;itok=ykribhW8 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1074&amp;a=0,231&amp;itok=K1QxWY-I 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1074&amp;a=0,231&amp;itok=ykribhW8 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,231&amp;itok=OgWyrFoS 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1415&amp;a=0,61&amp;itok=7hyTYd65 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1069&amp;a=0,234&amp;itok=_JzWdgqt 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1069&amp;a=0,234&amp;itok=gNI158Pw 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,231&amp;itok=Qwetc58Q 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,231&amp;itok=E0Qx556e 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,231&amp;itok=hXS-UyZz 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,231&amp;itok=e_XprPGT 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,231&amp;itok=hXS-UyZz" width="400" height="210" alt="Cells" title="Cells" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Blog: Cell and gene therapy trials - delivering differently</h4> <div class="card-text small"> <div> <p>The success of cell and gene therapies (CGT) has transformed the delivery of clinical trial services, requiring the design of new workflows, processes and tools.</p> </div> </div> </div> </div> </a> </li> <li> <a href="/insights/blog/2019/06/10/act-trials-demand-that-sites-act-differently" class="block-link" target="_self"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=OASAiDM0 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=yqiHNm2B 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=OASAiDM0 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=yqiHNm2B 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=a3n4IqU8 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=256&amp;a=0,57&amp;itok=X0UxxuWA 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,89&amp;itok=Zjo2MaVM 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,89&amp;itok=iTdRN4aF 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=bgZYDLqH 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=WzW2CS3I 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=QV5xz4OK 1x, https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=jHiuzHOn 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/wxgajheqrh/web/oncology-tumor.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,88&amp;itok=QV5xz4OK" width="400" height="210" alt="oncology-tumor" title="oncology-tumor" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Blog: Adoptive cellular transfer trials demand that participating sites act differently</h4> <div class="card-text small"> <div> <p>The evolution of adoptive cellular transfer (ACT) for the treatment of lymphoma, leukaemia and myeloma patients has grown exponentially.</p> </div> </div> </div> </div> </a> </li> <li> <a href="/insights/blog/2020/06/22/enabling-clinical-development-of-cell-and-gene-therapies-on-a-global-basis" class="block-link" target="_self"> <div class="card card--overlapping-img text-left card--overlapping-img-green-dark"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1074&amp;a=0,0&amp;itok=cb5fDo57 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1074&amp;a=0,0&amp;itok=CU5Rs7fP 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1074&amp;a=0,0&amp;itok=cb5fDo57 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1074&amp;a=0,0&amp;itok=CU5Rs7fP 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,0&amp;itok=TAwpqTqg 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1415&amp;a=0,0&amp;itok=zLr5uT6W 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1069&amp;a=0,0&amp;itok=5EQqzaIW 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1069&amp;a=0,0&amp;itok=vdQFZEPU 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,0&amp;itok=k3mDJe7T 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,0&amp;itok=hg4qdygi 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,0&amp;itok=q05a_2cz 1x, https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,0&amp;itok=KjLK6QaY 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/t9avsejmcg/web/Cells.jpg?crop=yes&amp;w=2048&amp;h=1075&amp;a=0,0&amp;itok=q05a_2cz" width="400" height="210" alt="Cells" title="Cells" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Blog: Enabling clinical development of cell and gene therapies on a global basis</h4> <div class="card-text small"> <div> <p>Clinical trials for cell and gene therapies (CGT) present unique challenges as they require special resources and training.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.appliedclinicaltrialsonline.com/view/best-practices-in-managing-cgt-from-protocol-design-to-data-management" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=FW_LOZM7 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=306nNjvp 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=FW_LOZM7 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=306nNjvp 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=zOohrENK 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=A6sXvDR3 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=TD2Wf1pD 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=PPMZGd1a 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=ztHIGYmB 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=6R_2IHyU 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=-dLUW4_C 1x, https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=YWrzARMm 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/mn2bsr6a8z/web/cell-and-gene-therapeutics.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=-dLUW4_C" width="400" height="210" alt="cell-and-gene-therapeutics" title="cell-and-gene-therapeutics" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Best practices in managing CGT from protocol design to data management</h4> <div class="card-text small"> <div> <p>As this new frontier of medicine continues to expand a growing number of pharmaceutical and biotech companies will delve into CGT clinical trials.&nbsp;</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www.biopharminternational.com/view/navigating-cell-therapy-manufacturing-amid-pandemic-woes" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=9Nbiawbo 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=gOHuWOx5 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=9Nbiawbo 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=gOHuWOx5 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=OZbspIno 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=QD-pZMfd 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=wSG459RW 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=kxHEs80a 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=OcrWf6F1 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=OP_p4z5Y 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=YaBPwF71 1x, https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=CU73iKqj 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/alzlvslxgi/web/cell-and-gene-therapy-iconography.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=YaBPwF71" width="400" height="210" alt="cell-and-gene-therapy-iconography" title="cell-and-gene-therapy-iconography" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Navigating cell therapy manufacturing amid pandemic woes</h4> <div class="card-text small"> <div> <p>Automation, digitalisation, and supply-chain strategies help mitigate vulnerabilities in both autologous and allogeneic cell therapy manufacturing.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www2.iconplc.com/insidersguide_2020" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=VTRnJQ1g 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=beHK9YUR 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=VTRnJQ1g 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=beHK9YUR 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=j-q9SzMv 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=HpC8IG2p 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=nKX28lXU 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=BdIxmzTk 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=7OIpPiC0 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=pTb7PcL7 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=U0vp7Gnr 1x, https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=y-tXJbnv 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/skqfgipxpn/web/cells-in-gene-therapy.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=U0vp7Gnr" width="400" height="210" alt="cells-in-gene-therapy" title="cells-in-gene-therapy" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Navigating complexity in cell and gene therapy clinical trials</h4> <div class="card-text small"> <div> <p>As more knowledge is revealed about the genetic underpinnings of cancers, cell and gene therapies (CGT) are playing an increasingly important role in treating oncology patients.(PDF)</p> </div> </div> </div> </div> </a> </li> <li> <a href="http://www.biopharminternational.com/cell-therapies-living-end-growth-opportunities" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=gzWJVN2i 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=vWMWst_Y 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=gzWJVN2i 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=vWMWst_Y 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=WIIodbO_ 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=AQBg4yFw 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=9oXjD4qU 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=ZG7p9wHW 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=91XAXbiH 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=5hul6eig 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=m19U34Cr 1x, https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=c6T4SnG6 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/skeroeapme/web/cell-gene-therapy-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=m19U34Cr" width="400" height="210" alt="cell-gene-therapy-image" title="cell-gene-therapy-image" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Cell therapies - the living end of growth opportunities</h4> <div class="card-text small"> <div> <p>As the incidence of chronic diseases, such as cancer, is rising, so too is the interest from industry in the area of cell and gene therapies.</p> </div> </div> </div> </div> </a> </li> <li> <a href="https://www2.iconplc.com/Article_Autologous_to_Allogeneic_ACT.pdf" class="block-link" target="_blank"> <div class="card card--overlapping-img text-left card--overlapping-img-blue"> <div class="image image--zoom-on-hover"> <div> <div> <picture> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=PbGDTv35 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=7qmHunx3 2x" media="(min-width: 1400px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=PbGDTv35 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=7qmHunx3 2x" media="(min-width: 1200px)" width="370" height="194"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=MnTTEA3d 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=281&amp;h=194&amp;a=45,0&amp;itok=e43MULe9 2x" media="(min-width: 992px) and (max-width: 1199px)" width="301" height="158"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=hjI29Nc0 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=193&amp;a=0,1&amp;itok=04m73GOY 2x" media="(min-width: 768px) and (max-width: 991px)" width="226" height="118"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=Vln08-NT 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=73VzHYfT 2x" media="(min-width: 576px) and (max-width: 767px)" width="400" height="210"/> <source srcset="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=0p_T9-Y6 1x, https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=24er3Ylp 2x" media="(max-width: 575px)" width="400" height="210"/> <img src="https://icon.widen.net/content/ku0xwfavut/web/cell-gene-therapy-blue-image.jpg?crop=yes&amp;w=370&amp;h=194&amp;a=0,0&amp;itok=0p_T9-Y6" width="400" height="210" alt="cell-gene-therapy-blue-image" title="cell-gene-therapy-blue-image" loading="lazy" /> </picture> </div> </div> </div> <div class="card-body overlapping-comp" data-mh="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <h4 class="card-title">Media article: Clinical development operational implications of the move from autologous to allogeneic ACT paradigms</h4> <div class="card-text small"> <div> <p>Allogeneic CAR-T cells can be manufactured using T cells from just one, single healthy donor and can be used in multiple patients. (PDF)</p> </div> </div> </div> </div> </a> </li> </ul> </div> </div> </div> <div id="8dfde6c4-5b64-47a5-8a72-9f82e9fd0d38"> <div class="bg-gray"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture-wrapper"> <div class="text-picture text-picture--text-only text-left with-separator--top"> <div> <div class="text-picture__text"> <h2>Receive more insights on cell and gene therapies from ICON</h2> <h3> </h3> <div> <p>Please visit ICON's <a href="/preferences/" target="_self">Preference Centre</a> and select '<strong>Cell and Gene Therapies</strong>' under '<strong>Therapeutic Areas of Interest</strong>' to receive new insights on cell and gene therapies.</p> </div> <a class="btn btn-primary btn-md" href="/preferences" target="_blank">Receive new insights </a> </div> </div> </div> </div> </div> </div> </div> </div> </div><div id="3e8f62a2-e9c7-4328-9778-61eda42c627e"> <div class="container-fluid container-fluid--xl"> <div class="video-player video-player--standard embed-responsive embed-responsive-16by9"> <div class="embed-responsive-item"> <video-js data-account="108289197001" data-player="crX3brXch" data-embed="default" controls="" data-video-id="6327755788112" data-playlist-id="" data-application-id=""> </video-js> <script src="https://players.brightcove.net/108289197001/crX3brXch_default/index.min.js"></script> </div> <div class="video-label"></div> </div> </div> </div> <div id="7b6ea38a-c568-44ae-a3c2-1b7d99eaf173"> <div class="bg-gray"> <div class="container-fluid container-fluid--xl text-and-picture-wrapper") }}> <div class="row"> <div class="col-sm"> <div class="text-picture-wrapper"> <div class="text-picture text-picture--text-only text-left with-separator--top"> <div> <div class="text-picture__text"> <h2>Cell and Gene Therapies at ICON</h2> <h3> </h3> <div> <p>ICON’s Cell and Gene Therapy (CGT) Solution was designed to expedite every aspect of a cell therapy clinical trial and address specific needs of CGT product development. The CGT Leadership Team leads your trials with innovative technologies and standardised tools for CGT trial execution, management of high data volumes, and extensive team and site training. Read more about ICON's services.</p> <p>&nbsp;</p> </div> <a class="btn btn-primary btn-md" href="/therapeutics/cell-and-gene-therapies" target="_self">Read more about ICON&#039;s services in cell and gene therapies </a> </div> </div> </div> </div> </div> </div> </div> </div> </div><div id="682d5c67-6afd-40a2-99c0-314a4198f48d"> <div class="group group--with-carousel bg-white content-visibility--auto contain-intrinsic-size--400 related-content-carousel"> <div class="container-fluid container-fluid--xl"> <h2 class="group__title"> Related information </h2> <div class="carousel--standard carousel--standard-1-3-4"> <a class="carousel__item block-link" href="/therapeutics/cell-and-gene-therapies" target="_self"> <div class="card card--with-solid-bg card--with-solid-bg-green" data-mh="related-content"> <div class="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <span class="badge badge--with-arrow">Webpage</span> <h4 class="card-title m-0"> Cell and Gene Therapy development services </h4> </div> </div> </a> <a class="carousel__item block-link" href="/therapeutics/oncology" target="_self"> <div class="card card--with-solid-bg card--with-solid-bg-green" data-mh="related-content"> <div class="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <span class="badge badge--with-arrow">Webpage</span> <h4 class="card-title m-0"> ICON&#039;s Oncology services </h4> </div> </div> </a> <a class="carousel__item block-link" href="/therapeutics/central-nervous-system" target="_self"> <div class="card card--with-solid-bg card--with-solid-bg-green" data-mh="related-content"> <div class="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <span class="badge badge--with-arrow">Webpage</span> <h4 class="card-title m-0"> ICON&#039;s CNS development services </h4> </div> </div> </a> <a class="carousel__item block-link" href="/therapeutics/internal-medicine-and-immunology/ophthalmology" target="_self"> <div class="card card--with-solid-bg card--with-solid-bg-green" data-mh="related-content"> <div class="card-body"> <i aria-hidden="true" class="icon-ui-arrow-right"></i> <span class="badge badge--with-arrow">Webpage</span> <h4 class="card-title m-0"> Ophthalmology </h4> </div> </div> </a> </div> </div> </div> </div> </div> </div> </div> </article> </div> </div> </div> </main> <footer role="contentinfo" class="footer"> <div class="footer__main-content"> <div class="container-fluid container-fluid--xl"> <div region="footer" class="row"> <div class="col-12 col-md-3"> <div class="h6 footer__nav-title">Site Branding</div> <ul class="footer__nav--secondary list-unstyled secondary-nav-title"> <img alt="ICON plc" title="ICON plc" class="footer__logo" height="38" src="/themes/custom/iconplc/src/assets/images/ICON_positive_logo.svg" width="138"> <li> <a href="/contact" data-drupal-link-system-path="node/33596">Contact</a> </li> <li> <a href="/about" data-drupal-link-system-path="node/33564">About ICON</a> </li> <li> <a href="https://investor.iconplc.com/financials-filings/annual-reports" target="_blank">Results &amp; Reports</a> </li> </ul> </div> <div class="col-6 col-md-2"> <div class="h6 footer__nav-title">For Clients</div> <ul class="footer__nav--secondary list-unstyled secondary-nav-title"> <li> <a href="/therapeutics" data-drupal-link-system-path="node/34075">Therapeutics</a> </li> <li> <a href="/solutions" data-drupal-link-system-path="node/33933">Solutions</a> </li> <li> <a href="/insights" data-drupal-link-system-path="node/33625">Insights</a> </li> <li> <a href="/solutions/technologies" data-drupal-link-system-path="node/34042">Technologies</a> </li> <li> <a href="/preferences" data-drupal-link-system-path="node/33791">Content preferences</a> </li> <li> <a href="/contact/global-office-locator" data-drupal-link-system-path="node/33595">Office locations</a> </li> </ul> </div> <div class="col-6 col-md-2"> <div class="h6 footer__nav-title">ICON for</div> <ul class="footer__nav--secondary list-unstyled secondary-nav-title"> <li> <a href="https://www.accellacare.com/" target="_blank">Patients</a> </li> <li> <a href="https://iconstudies.com/" target="_blank">Volunteers</a> </li> <li> <a href="/investigators" data-drupal-link-system-path="node/33762">Investigators</a> </li> <li> <a href="https://careers.iconplc.com/" target="_blank">Jobs &amp; Careers</a> </li> <li> <a href="https://investor.iconplc.com/" target="_blank">Investors</a> </li> <li> <a href="/procurement-terms/icon-suppliers">Suppliers</a> </li> </ul> </div> <div class="col-12 col-md-2"> <div class="h6 footer__nav-title">News &amp; Events</div> <ul class="footer__nav--secondary list-unstyled secondary-nav-title"> <li> <a href="/news-events/press-releases" data-drupal-link-system-path="node/33789">Press releases</a> </li> <li> <a href="/news-events/mediakit" data-drupal-link-system-path="node/33787">Mediakit</a> </li> <li> <a href="/news-events/events" data-drupal-link-system-path="node/34258">Events</a> </li> <li> <a href="/news-events/social-media" data-drupal-link-system-path="node/33790">Social media dashboard</a> </li> </ul> </div> <div class="col-12 col-md-3"> <div class="h6 footer__nav-title">Socials</div> <ul class="footer__nav--secondary list-unstyled secondary-nav-title"> <li class="list-inline-item"> <a class="linkedin" href="https://www.linkedin.com/company/icon-plc-2" target="_blank" title="Icon on Linkedin"> <i aria-hidden="true" class="fa fa-linkedin"></i><span class="sr-only">Linkedin</span> </a> </li> <li class="list-inline-item"> <a class="x-twitter" href="https://twitter.com/ICONplc" target="_blank" title="Icon on Twitter"> <i aria-hidden="true" class="fa fa-x-twitter"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M389.2 48h70.6L305.6 224.2 487 464H345L233.7 318.6 106.5 464H35.8L200.7 275.5 26.8 48H172.4L272.9 180.9 389.2 48zM364.4 421.8h39.1L151.1 88h-42L364.4 421.8z" fill="currentColor"/></svg> </i> </a> </li> <li class="list-inline-item"> <a class="facebook" href="https://www.facebook.com/icon.plc.profile" target="_blank" title="Icon on Facebook"> <i aria-hidden="true" class="fa fa-facebook"></i><span class="sr-only">Facebook</span> </a> </li> <li class="list-inline-item"> <a class="instagram" href="https://www.instagram.com/iconplc/" target="_blank" title="Icon on Instagram"> <i aria-hidden="true" class="fa fa-instagram"></i><span class="sr-only">Instagram</span> </a> </li> <li class="list-inline-item"> <a class="youtube" href="https://www.youtube.com/user/ICONPlc" target="_blank" title="Icon on Youtube"> <i aria-hidden="true" class="fa fa-youtube"></i><span class="sr-only">Youtube</span> </a> </li> </ul> </div> </div> </div> </div> <div class="copyright"> <div class="container-fluid container-fluid--xl"> <nav role="navigation" aria-labelledby="block-legalfooter-menu" id="block-legalfooter"> <h2 class="visually-hidden" id="block-legalfooter-menu">Legal Footer</h2> <ul region="legal_footer" class="list-inline"> <li class="list-inline-item"> <span>© 2024 ICON plc</span> </li> <li class="list-inline-item"> <a href="https://iconplc.com/disclaimer/">Disclaimer</a> </li> <li class="list-inline-item"> <a href="/privacy" data-drupal-link-system-path="node/33795">Privacy &amp; Data</a> </li> <li class="list-inline-item"> <a href="https://iconplc.com/site-cookies/">Cookies</a> </li> </ul> </nav> </div> </div> </footer> </div> <div class="modal modal--ajax-search fade" id="search-modal" tabindex="-1" role="dialog" aria-labelledby="search-modal"> <div class="modal-dialog" role="document" id="searchApp"> <div class="modal-content"> <div class="modal-header"> <div class="h1 modal-title">How can we help?</div> <button type="button" class="close" data-dismiss="modal" aria-label="Close"> <span class="sr-only">Dismiss Search Modal</span> </button> </div> <div class="modal-body"> <div class="region region-offscreen"> <div class="modal--ajax-search" id="block-searchblock"> <div class="modal-content"> <div id="icon-search-bar" class="icon-search-bar modal-body"> <form action="/live-search" autocomplete="off" id="site-search" role="search" class="form--simple-search"> <ul class="nav nav-tabs search-global-filter" role="tablist"> <li class="nav-item search-nav-tab"><a class="nav-link show-all active" data-display-id="all">All</a></li> <li class="nav-item search-nav-tab"><a class="nav-link" data-toggle="tab" href="#website" data-display-id="website">Website</a></li> </ul> <div class="search-results-input"> <div class="input-group"> <input class="form-control form-control--simple" id="icon-search-input" type="text" placeholder="Live search..."/> <span class="input-group-btn"> <button class="btn btn-lg btn-primary primary-search-button"><span class="icon-search-indicator icon-ui-search-loupe"></span><span class="sr-only">Search</span></button> </span> </div> </div> <div class="list-with-scroll"> <div class="popular-search-terms"> <div class="list-with-scroll__label"> Popular search terms:</div> <ul class="list-inline search-terms"> <li class="list-inline-item search-term"><a class="search-term-tag">Biotech</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Cell and Gene Therapies</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Consulting</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Early Clinical</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Medical Device</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Oncology</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Rare &amp; Orphan Diseases</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Real World Evidence</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Site &amp; Patient Recruitment</a></li> <li class="list-inline-item search-term"><a class="search-term-tag">Strategic Solutions</a></li> <li class="list-inline-item search-term"><a class="search-term-tag"> Regulatory Intelligence</a></li> </ul> </div> <div class="hide-global-filters global-filters-facet"> <label for="globalFilterReset" class="list-with-scroll__label">Categories</label> <button type="button" class="badge badge-primary global-filter-button" id="globalFilterReset"></button> </div> </div> <div class="taxonomy-term-facet-filter"></div> </form> <div class="tab-content"> <div id="website" class="p-0 container tab-pane active show"> <div id="icon-search-results--insights_block"></div> <div id="icon-search-results--other_web_pages"></div> </div> </div> </div> </div> </div> </div> </div> <div class="modal-footer"></div> </div> </div> </div> </div> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/33674","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJyFkWFyhCAMhS8kciQnQFboRsKEuF17-qK21jrb6a88vvfIkAAhKENeLHyJ_iactYM3eA7EEFDsSfcahZ1D6TwL2swyAaUP7JLnPDhJY1TPD7Sn87CCPVARxEe7lw0V8taDBGNaSAhKSXk0aYIRL35VyKGpC35PGg0-SzPXm4pPfZWoTCkYN549nivSi8YjsQNqfKHW8sBrNTdmbdP_YhHX1RysCE9sPE-FM2a98EcK-Mrdd2Icsb8fcJ3GlOR1FjSHILzpNqjZ9vtHejtt0W_0b5ozLR3BwrMOIdX132Sx7Z2eqSsgMAqUWG2QuQD1P6Sfc5kdpRoxdHWpipN1UPETBWDpTw","theme":"iconplc","theme_token":null},"ajaxTrustedUrl":[],"ajaxLoader":{"markup":"\u003Cdiv class=\u0022ajax-throbber sk-circle-fade\u0022\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003Cdiv class=\u0022sk-circle-fade-dot\u0022\u003E\u003C\/div\u003E\n \u003C\/div\u003E","hideAjaxMessage":true,"alwaysFullscreen":true,"throbberPosition":".acquia-dam-media-library"},"clientside_validation_jquery":{"validate_all_ajax_forms":2,"force_validate_on_blur":false,"messages":{"required":"This field is required.","remote":"Please fix this field.","email":"Please enter a valid email address.","url":"Please enter a valid URL.","date":"Please enter a valid date.","dateISO":"Please enter a valid date (ISO).","number":"Please enter a valid number.","digits":"Please enter only digits.","equalTo":"Please enter the same value again.","maxlength":"Please enter no more than {0} characters.","minlength":"Please enter at least {0} characters.","rangelength":"Please enter a value between {0} and {1} characters long.","range":"Please enter a value between {0} and {1}.","max":"Please enter a value less than or equal to {0}.","min":"Please enter a value greater than or equal to {0}.","step":"Please enter a multiple of {0}."}},"searchPageUrl":"\/live-search","csp":{"nonce":"eQsl2Ue5QCG9x06ZF63eZw"},"user":{"uid":0,"permissionsHash":"f01f36190caa010d94e570540a4b4f3142bad09d60a47161bcbb58d60194bee8"}}</script> <script src="/sites/default/files/js/js_4eyK4OIDo-cHA2vFhqDgYHqy_-DGeewODAUoq8QSoxA.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=iconplc&amp;include=eJyFUtFyxCAI_KEQPymDSqItEQfN9dKvr0l6ae6m0z4Byw7souh9FUyrwe-kH1VS7fAN7wMLelJzyfsaVKwl7cpaKs3GYqHOiZJJojNy_KQuOkmZnZlYLDKUunJM0w4PhVBdMEc4mUcJlsW9n-AWYRSpbRvjKksdfCxObqSrkUROuMuoOCnmUIzXJSP3P0i_pLxYjiWQP4c6VA_wEWuAIhw92Onak6UQQ5OMyTfm2ap0r5Cjq4sSwF5J4vXsZ5VZ4BY9CTiZc5PXjrg7thqnUDfZ5lIPG_CbKrrntrvda9_ywti8M-a8teOM0-uEf3Q_EqaxHiZ2LX-53KkP6Jl9eH52e75boO27fAGaNOlP"></script> <script src="https://static.addtoany.com/menu/page.js" async></script> <script src="/sites/default/files/js/js_c2AigUjCra9_0qHIiFPt_25sPCfByTjnVS-JS7IQ6yg.js?scope=footer&amp;delta=2&amp;language=en&amp;theme=iconplc&amp;include=eJyFUtFyxCAI_KEQPymDSqItEQfN9dKvr0l6ae6m0z4Byw7souh9FUyrwe-kH1VS7fAN7wMLelJzyfsaVKwl7cpaKs3GYqHOiZJJojNy_KQuOkmZnZlYLDKUunJM0w4PhVBdMEc4mUcJlsW9n-AWYRSpbRvjKksdfCxObqSrkUROuMuoOCnmUIzXJSP3P0i_pLxYjiWQP4c6VA_wEWuAIhw92Onak6UQQ5OMyTfm2ap0r5Cjq4sSwF5J4vXsZ5VZ4BY9CTiZc5PXjrg7thqnUDfZ5lIPG_CbKrrntrvda9_ywti8M-a8teOM0-uEf3Q_EqaxHiZ2LX-53KkP6Jl9eH52e75boO27fAGaNOlP"></script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10